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ABSTRACT 
 
 
Fusion at highly specialized membrane microdomains is a prerequisite for processes like 
hormone and neurotransmitter release, antigen presentation and viral infection. Apart from a 
family of highly conserved proteins called SNAREs, membrane fusion also requires a set of 
regulatory lipids that includes ergosterol, diacylglycerol, phosphatidic acid and 
phosphoinositides. Although a lot is known about the SNARE protein machinery, the role of 
lipids and the lipid environment of the membrane are not clear. For long, lipids had been thought 
to play a passive role by binding protein factors through their lipid binding domains. However, 
recent studies have shown that a subset of lipids play critical regulatory role by modulating the 
SNARE fusion machinery.  
 
The regulatory role of lipids on the fusion machinery can be divided into at least two 
mechanisms. The first mechanism depends on the direct chemical interaction of lipids with the 
protein fusion catalysts. Here, we report that phosphatidic acid serves to bind a key AAA+ 
family ATPase, Sec18p that effects priming in yeast vacuolar membrane fusion. The yeast PA 
phosphatase Pah1p alters the ratio of PA to DAG on the membrane during priming and serves to 
recruit Sec18p to the cis-SNARE complexes at the site of priming. 
 
The second mechanism is indirect and physical and is dictated by the physical parameters 
of the membrane such as curvature, fluidity and lateral tension. We report that inducing negative 
curvature on the vacuole membrane lowers the force threshold required for fusion, thus allowing 
non-canonical SNARE complexes to support fusion. On the other hand, increasing the positive 
curvature of the membrane increases the force threshold such that even canonical SNARE 
complexes do not support fusion. We also report that the formation of the SNARE bundle and 
the presence of a transmembrane domain serve to transmit the pulling force generated from the 
SNARE bundle to the membrane, which serves to distort the lipid bilayer leading to fusion. 
Either a defect in the SNARE complex or the absence of a transmembrane leads to a break in 
force transmission and thus results in fusion stalled at the hemifusion stage.  
 
 iii 
 
The knowledge gained from this study sheds more light on the mechanism by which 
membrane lipids regulate fusion. We have demonstrated that regulatory lipids are important 
during distinct stages of fusion and serve to recruit key protein catalysts at the site of fusion. The 
lipid composition of the membrane also dictates membrane parameters such as curvature and 
fluidity. We demonstrate that membrane curvature, fluidity and lateral tension are essential 
factors that can affect the core fusion machinery. The contribution of the membrane in 
membrane fusion is only beginning to be understood and we hope that this study will contribute 
to a growing sea of knowledge in the field of membrane fusion. 
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Luxury it is, to choose the road less travelled 
But there are no roads leading to your own little hollow 
Get ready to pave your own path 
And leave signs for those who follow 
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OVERVIEW 
 
The transport of cargo through the endocytic and secretory pathways is controlled by 
machinery that is conserved throughout eukaryotes [1]. In addition, membrane fusion is essential 
for the release of neurotransmitters, antibodies, as well as the turnover of receptors, the 
destruction of pathogens and the generation of antigens [2-6]. The final stage in these pathways 
is the fusion of membranes and transfer of cargo through a mechanism catalyzed by NEM-
sensitive factor attachment protein receptor (SNARE) proteins. All SNAREs contain a heptad-
repeat termed a “SNARE motif” that is often flanked by various N-terminal domains and C-
terminal membrane anchors [7]. SNAREs form parallel four helical bundles through their 
SNARE motifs, which are primarily composed of hydrophobic residues with the exception of a 
conserved central glutamine (Q), or arginine (R) that interact in the ionic zero-layer [8] (Fig 1.1). 
Each functional SNARE bundle is composed of 3 Q-SNARE coils and 1 R-SNARE coil. Yeast 
vacuole fusion depends on the Q-SNAREs Vam3p, Vam7p and Vti1p, and the R-SNARE 
Nyv1p. Vacuole fusion also requires the Rab GTPase Ypt7p and its effector complex HOPS [9]. 
             These shared elements of the trafficking sytems provide the basic outline for a 
conserved fusion mechanism. Fusion at highly specialized membrane microdomains is a 
prerequisite for processes like hormone and neurotransmitter release, antigen presentation and 
viral infection. Thus, studying and understanding the regulation and deregulation of these 
pathways in disease states and in infection will shed more light on the various biological 
processes that share the conserved fusion machinery. 
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STAGES OF MEMBRANE FUSION 
 
Vacuole fusion occurs through a series of phases that have been experimentally defined. 
The fusion cascade is initiated when the AAA+ protein Sec18pp (NSF) and Sec17p (-SNAP) 
prime inactive cis-SNARE complexes [9,10]. Disruption of cis-SNARE complexes leads to the 
dissociation of Sec17p as well as the soluble SNARE Vam7p [11,12]. Between priming and 
fusion, membranes undergo the tethering and docking stages that are controlled by a Rab 
GTPase and its effector molecules, which include tethering molecules, nucleotide exchange 
factors, GTPase activating proteins, and Sec/Munc proteins [13]. In yeast, primed vacuoles 
become reversibly docked through the function of Ypt7p and its effector complex HOPS [14,15]. 
Vacuole fusion occurs at highly organized membrane rafts termed vertex microdomains that 
form at the point of contact between partner vacuoles, and become enriched in the regulatory 
lipids and proteins required for fusion [16,17]. During the docking stage Vam7p rebinds through 
its interactions with the hetero-hexameric tethering complex HOPS and the lipid 
phosphatidylinositol 3-phosphate (PtdIns(3)P), and enters a trans-SNARE complex [18]. The 
formation of the trans-SNARE complexes triggers the release of Ca
2+
 from the vacuole lumen 
[19]. The penultimate step in fusion is a hemifusion intermediate where the closely apposed 
outer membrane leaflets fuse without fusing the inner leaflets [20]. The fusion pathway 
culminates with the fusion of inner leaflets and content mixing.  
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TOOLS TO STUDY MEMBRANE FUSION 
 
 A wide range of assay methods have been developed to study and monitor yeast vacuole 
membrane fusion. The most widely used assay makes use of the two yeast strains BJ3505 and 
DK6281. To assay fusion, vacuoles are isolated from these two strains, one with normal vacuolar 
proteases but deleted of the major phosphatase encoding gene Phop8 and the other deleted of the 
vacuolar protease Pep4p and hence unable to activate the catalytically-inactive pro-Pho8p. 
Neither population of vacuoles has phosphatase activity (Fig 1.2). Upon fusion, the vacuolar 
proteases gainaccess to the inactive pro-Pho8p and converts it to the active form. The activity of 
the active Pho8p can be assayed colorimetrically by using p-nitrophenylphosphate as the 
substrate, which is converted to p-nitrophenylate. 
 
Another widely used assay to monitor membrane fusion, involves the dequenching of 
rhodamine labeled Phosphatidylethanolamine following membrane fusion and lipid mixing. 
Here, the outer leaflets of vacuoles are labeled with Rh-PE at levels that cause self-quenching of 
the fluorophore. Labeled vacuoles are mixed with an excess of unlabeled vacuoles and the fusion 
of the outer leaflets is measured by an increase in fluorescence due to the dilution and 
dequenching of Rh-PE in the hemifused vacuoles. Other widely used assay methods involve 
monitoring the increase in vacuole diameter by microscopy, reconstitution of the two subunits of 
the -lactamase enzyme upon fusion. 
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REGULATION OF THE MEMBRANE FUSION MACHINERY 
 
Vacuole fusion also requires a group of regulatory lipids that include ergosterol, 
diacylglycerol (DAG), phosphatidic acid (PA), as well as multiple phosphoinositides [12,16,21-
24]. Moreover, the modification of these lipids plays an important role throughout the fusion 
pathway. For instance, DAG is produced by the phospholipase C activity of Plc1p on 
Phosphatidylinoslitol(4,5)P2, or through the phosphatase activity of Pah1p on PA [21,25]. In both 
pathways the inhibition of DAG production severely inhibits vacuole fusion. The direct binding 
of lipids by soluble ligands can also perturb fusion at different stages of the pathway. Binding 
ergosterol or PtdIns(4,5)P2 is known to inhibit at the priming stage, whereas binding PtdIns(3)P 
inhibits at the docking stage by preventing the rebinding of Vam7p to the membrane via its Phox 
domain [12,22]. The role of lipids on the fusion machinery can be divided into at least two 
mechanisms. The first mechanism depends on the direct chemical interaction of lipids with the 
protein fusion catalysts, which is exemplified by the interaction of the Vam7p PX domain with 
PtdIns(3)P [26]. The second mechanism is indirect and physical [27]. This is demonstrated by 
the dependence of SNARE function on the assembly of metabolically active membrane raft 
microdomains [16]. The assembly of ergosterol-rich microdomains affects the local 
microviscosity of the membrane and can potentially exert allosteric effects on the transmembrane 
domains (TMDs) of Vam3p, Vti1p, and Nyv1p. The concentration of specific lipids into small 
domains, which may increase avidity, also regulates direct protein-lipid interactions and the 
dynamics of vacuole associated actin [16,24].  
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FIGURES 
 
 
 
 
 
 
 
Fig 1.1 A canonical 3Q:1R SNARE complex showing the 0-ionic layer. Figure reproduced with permission 
from © Nature Reviews, Molecular Cell Biology, Volume 7,  September 2006, pg: 633. 
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Fig 1.2 : Alkaline phosphatase maturation assay to study membrane fusion. 
 © Haas et al., 1994. Originally published in JCB. 126 :87-97. 
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SUMMARY 
 
Yeast vacuole fusion requires the formation of SNARE bundles between membranes. Although 
the function of vacuolar SNAREs is controlled by regulatory lipids, the exact role of the 
membrane in regulating fusion remains unclear. Because SNAREs are membrane-anchored and 
transmit the force required for fusion to the bilayer, we hypothesized that the lipid composition 
and curvature of the membrane aid in controlling fusion. Here, we examined the effect of 
altering the activation energy of fusion on the functionality of fusion-incompetent SNARE 
mutants that are thought to generate insufficient force to trigger the hemifusion-fusion transition. 
The hemifusion-fusion transition was inhibited by disrupting the 3Q:1R stoichiometry of 
SNARE bundles with the mutant SNARE Vam7p
Q283R
. Similarly, replacing the transmembrane 
domain of the syntaxin homolog Vam3p with a lipid anchor allowed hemifusion, but not content 
mixing. Hemifusion-stalled reactions containing either of the SNARE mutants were stimulated to 
fuse with chlorpromazine, an amphipathic molecule that alters membrane fluidity and curvature, 
and affects the activation energy of fusion. The activity of mutant SNAREs was also rescued by 
the overexpression of SNAREs, thus multiplying the force transferred to the membrane. Thus, 
we conclude that either lowering the activation energy, or multiplying SNARE-generated energy 
restored the fusogenicity of mutant SNAREs that are stalled at hemifusion. We also found that 
regulatory lipids differentially modulated the complex formation of wild-type SNAREs. 
Together, these data indicate that the physical properties and the lipid composition of the 
membrane regulate the function of SNAREs in promoting the hemifusion-fusion transition. 
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INTRODUCTION 
 
The direct role of SNARE proteins on fusion is generally thought to occur through the 
transfer of energy generated from the formation of trans-SNARE complexes to the membrane 
and reaching the activation energy of the fusion reaction [28]. Fusion is attenuated when the 
TMD of Vam3p or Nyv1p are exchanged for lipid anchors, or when the 3Q:1R paradigm is 
altered by mutating Vam7p or Nyv1p at the ionic zero layers of their SNARE motifs [29-31]. 
The defects in triggering fusion lie downstream of trans-SNARE complex formation, leading to 
the hypothesis that these SNARE complexes exert insufficient force to overcome the activation 
energy of fusion and may be stalled at the hemifusion stage. In this study we examined whether 
modifications in membrane fluidity (lateral mobility) and curvature (membrane bending), or the 
overexpression of SNAREs could compensate for the inability of non-fusogenic mutant SNAREs 
in triggering fusion. We report that non-canonical 2Q:2R SNARE complexes as well as those 
containing lipid-anchored Vam3p that normally do not support vacuole fusion can be stimulated 
to trigger fusion by lowering the activation energy required for the hemifusion-fusion transition. 
We also found that a subset of regulatory lipids controls the assembly and function of wild type 
SNARE complexes and their interactions with the HOPS complex.  
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RESULTS 
 
The central ionic residue of SNARE motifs is conserved throughout eukaryotes and is 
essential for fusion, and each fusogenic SNARE bundle is composed of 3 Q-SNAREs and 1 R-
SNARE (3Q:1R). Previously, we found that point mutations yielding 2Q:2R complexes were 
fusion incompetent and that fusion was restored when membrane fluidity was increased with 
chlorpromazine (CPZ) [30]. CPZ is an amphipathic small molecule that traverses the lipid 
bilayer and inserts itself into the inner leaflet of membranes thereby increasing the negative 
curvature of the outer leaflet of the bilayer [32]. A wealth of knowledge on the effects of CPZ on 
membrane physical properties has been gained from force measurements on the outer hair cell of 
the mammalian cochlea. CPZ decreases the steady state tethering force and increases lateral lipid 
mobility in outer hair cell membrane tethers [33]. It also decreases the lateral cell wall tension 
required for vesicle generation in the plasma membrane of the outer hair cell [34].  We theorize 
that these changes effectively lower the activation energy of the fusion reaction to a level 
attainable for the 2Q:2R SNARE complex. Here, we continue to examine the regulatory role of 
lipid composition and curvature on SNARE function. We first compared the effects of CPZ on 
the ability of recombinant Vam7p to bypass anti-Sec17 antibody inhibited fusion. In these 
experiments, SNARE priming was inhibited with antibody against Sec17p, after which 
increasing concentrations of recombinant wild type Vam7p or Vam7p
Q283R
 was added to 
stimulate fusion. Similar to previous findings [30], we found that Vam7p
Q283R
 was unable to 
bypass the anti-Sec17p block (Fig. 2.1A, solid squares), whereas wild type Vam7p demonstrated 
the characteristic biphasic curve of bypass fusion with maximum activity between 50 and 100 
nM (Fig. 2.1A, solid circles). Treating fusion reactions with CPZ prior to adding Vam7p
Q283R
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restored fusion to near wild type levels (Fig. 2.1A, open squares); however, this required a 10-
fold increase in Vam7p
Q283R
. Interestingly, CPZ inhibited the fusion bypass expected with low 
concentrations (10-50 nM) of wild type Vam7p (Fig. 2.1A, open circles). The inhibitory effect of 
CPZ on wild type Vam7p was overcome at higher concentrations without losing the biphasic 
characteristic of the curve.  
 
 Because CPZ reduced the efficacy of Vam7p at low concentrations during bypass 
reactions, we next tested whether CPZ altered the binding of Vam7p to the membrane. To 
determine this we added a dose curve of GST-Vam7p to anti-Sec17p antibody-blocked reactions 
in the presence or absence of CPZ. After incubation, the membrane fractions were re-isolated 
and probed for bound GST-Vam7p by immunoblotting. In Figure 2.1B we show that treatment 
with CPZ did not alter the binding of Vam7p to vacuoles, indicating that the differences 
observed in fusion were likely due to the effect of CPZ on membrane curvature and lateral 
tension. However, these data do not indicate whether Vam7p entered into the required level of 
functional SNARE complexes. Vacuole extracts were also probed for the presence of membrane-
anchored Ypt7p as a control for gel loading. It is possible that CPZ decreases lateral bilayer 
tension such that low concentrations of Vam7p, and hence low numbers of trans-SNARE pairs, 
were insufficient to stimulate fusion, and that this block was overcome at higher concentrations 
of Vam7p. To address this, we tested whether the order in which the Vam7p and CPZ were 
added altered the efficacy of Vam7p in stimulating fusion. We hypothesized that the addition of 
Vam7p prior to CPZ would allow the soluble SNARE to form sufficient numbers of fusion 
competent protein complexes. Consistent with our hypothesis, we found that adding Vam7p 
before CPZ improved bypass fusion when compared with reactions where CPZ was added prior 
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to Vam7p (Fig. 2.1C). When CPZ was added to fusion reactions that lacked anti-Sec17 antibody, 
we found that CPZ moderately reduced fusion whether it was added before or after exogenous 
GST-Vam7p (Fig.2 1D). Together these data suggest that the physical properties of a membrane 
(e.g. lateral bilayer tension and curvature changes due to membrane bending) can regulate the 
efficiency of SNARE mediated fusion. 
 
 Our previous studies showed that WT and Vam7p
Q283R
 form trans-SNARE complexes 
successfully [30], yet fusion required a 10-fold excess of Vam7p
Q283R
 to reach WT levels of 
fusion (Fig. 2.1A). Thus, we hypothesize that Vam7p
Q283R
 forms weaker SNARE bundles that do 
not exert sufficient force to reach the activation energy of fusion. Fusion was activated by CPZ, 
which in addition to selectively incorporating into the inner leaflets of membranes, has been 
reported to alter membrane curvature, lateral lipid mobility and bilayer tension [35]. CPZ activity 
has also been linked with promoting the transition of membranes from a hemifused to a fully 
fused state and lowering the energy required for pore formation [36]. Taken together, our data 
suggests that Vam7p
Q283R
 SNARE complexes exert insufficient force to trigger fusion following 
the trans-SNARE step and may be stalled in the hemifusion stage. To determine whether fusion 
mediated by Vam7
Q283R
 SNARE complexes is stalled before or after the hemifusion state, and to 
rule out vacuole lysis as the reason for observed differences between the WT and mutant Vam7p, 
we used a lipid-mixing assay that measures outer leaflet fusion alone [20,37]. Here, the outer 
leaflets of vacuoles were labeled with Rh-PE at levels that cause self-quenching of the 
fluorophore. Labeled vacuoles were mixed with an excess of unlabeled vacuoles and the fusion 
of the outer leaflets was measured by an increase in fluorescence due to the dilution and 
dequenching of Rh-PE in the hemifused vacuoles. We found that following a priming block 
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using anti-Sec17 antibody, both WT and Vam7p
Q283R
 equally supported lipid mixing in the 
absence of CPZ (Fig. 2.1E-F), suggesting that Vam7p
Q283R
 SNARE complexes are stalled at or 
after hemifusion. As a control, we used reactions that were inhibited with antibody against 
Vam3p or a mixture of Gyp1-56p and GDI to inhibit Ypt7p function. These control wells 
exhibited low levels of lipid mixing, indicating that since an earlier step in fusion (priming) was 
inhibited, these vacuoles could not move to the lipid mixing stage (Fig. 2.1E). This further 
suggests that the effect of CPZ on content mixing occurs after the hemifusion state. In addition, 
these data suggest that the ionic zero-layer of SNARE complexes serves as a checkpoint that 
needs to be passed to effect a transition from hemifusion to fusion. It should be noted that 
although the final extent of lipid mixing is the same, the kinetics of our experiment seem slower 
that the one reported in [38]. We attribute this difference to the fact that in our case, lipid mixing 
was monitored after the addition of recombinant Vam7p following a priming block with anti-
Sec17, whereas the previous report was an uninhibited reaction. It is possible that when priming 
is inhibited in these reactions, there is a lag between subsequent rounds of fusion and lipid 
mixing and hence displays slower kinetics.  
  
To further determine the effects of curvature and elasticity on vacuole fusion we 
compared the effects of CPZ with lysophosphatidylcholine (LPC), which is an inverted cone 
shaped lipid and intercalates into the outer leaflet of membranes leading to an increase in both 
positive curvature and tension [39]. Treating standard fusion reactions with LPC has been shown 
by others to inhibit vacuole fusion downstream of trans-SNARE complex formation [20]. This 
was likely due to the increase of activation energy to levels above those reached by SNARE 
complexes. Here, we compared the contrasting physical effects of CPZ and LPC in the bypass of 
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anti-Sec17 antibody blocked reactions by recombinant Vam7p. Fusion reactions were treated 
with buffer or anti-Sec17p antibody to block SNARE priming. Next, fusion reactions were 
further treated with buffer, CPZ, or LPC. As seen previously in Fig. 2.1, the addition of CPZ 
activated the fusogenic potential of Vam7p
Q283R
 (Fig. 2.2). In contrast to the effects of CPZ, 
treating with LPC blocked bypass fusion by both wild type and Vam7p
Q283R
.  
 
Because the order of addition altered the effects of CPZ on Vam7p-mediated bypass 
fusion, we tested whether pre-treating vacuoles with CPZ would nullify the inhibitory effect of 
LPC. When CPZ pre-treated vacuoles were subsequently treated with LPC we observed that 
fusion was completely inhibited to levels seen with LPC alone. Similarly, when LPC was added 
before CPZ treatment, bypass fusion was blocked with both wild type and mutant Vam7p (Fig. 
2.2). Membrane fusion can itself be viewed as a two-step process: an initial fusion of the outer 
leaflets and stalk formation, followed by the fusion of the inner leaflets and fusion pore 
formation [36]. Hemifusion could then be placed as an intermediate between these two steps, 
where stalk formation has occurred but inner leaflet fusion and pore formation have not. LPC has 
been reported to inhibit fusion by inhibiting stalk formation [40], whereas CPZ acts during the 
second stage of lipid mixing by promoting hemifusion-fusion transition. According to our data, 
the effects of LPC are dominant over the effects of CPZ because LPC inhibits the first step in 
lipid mixing, regardless of the order of incorporation of LPC or CPZ. The above experiment 
emphasizes how the shape of a lipid and hence its effect on the membrane curvature can be vital 
in supporting hemifusion at the sites of membrane fusion. 
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The previous experiments suggested that non-canonical SNARE complexes did not exert 
sufficient force on the membrane and were stalled in the hemifusion stage. Thus, we 
hypothesized that increasing the numbers of these weaker SNARE complexes (2Q:2R) on a 
membrane should result in enough pulling force to activate the hemifusion-fusion transition. To 
test this hypothesis, we used yeast strains that overexpressed the four vacuolar SNARE proteins 
to assay the efficacy of wild type and Vam7p
Q283R
 in the bypass of an anti-Sec17 antibody block. 
When using wild type vacuoles we found that 400 nM Vam7p rescued fusion as much as 70% of 
the uninhibited fusion, whereas, the Vam7p
Q283R
 mutant only partially rescued fusion (Fig. 2.3A; 
black bars). Consistent with previous figures, CPZ increased the bypass fusion by the 
Vam7p
Q283R 
mutant. When using vacuoles from SNARE overexpressing strains, we found that 
both the wild type and Vam7p
Q283R 
rescued fusion well beyond the positive control by 
approximately 225% and 150%, respectively (Fig. 2.3A; gray bars). The addition of CPZ further 
augmented fusion triggered by both wild type and Vam7p
Q283R
. These data demonstrate that non-
canonical SNARE complexes can overcome the activation energy barrier required for 
hemifusion-fusion transition when the surface density of the mutant SNARE complexes is 
multiplied. 
 
 To determine if more SNARE complexes were formed by exogenous GST-Vam7p, 
SNARE complexes were affinity isolated using glutathione agarose beads. We observed a clear 
increase in GST-Vam7p containing complexes in the presence of excess SNAREs. However, 
there were no observable differences between the wild type and Vam7p
Q283R
 in the presence or 
absence of CPZ (Fig.2.3B), indicating that the enhanced fusion was due to an increase in 
SNARE complex concentration. An earlier report suggests that the HOPS complex plays a more 
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direct role in fusion by proofreading and ensuring the integrity of the trans-SNARE complexes. 
The authors indicate that HOPS proofreads in two stages: it inhibits the formation of mismatched 
0-layer SNARE complexes and can suppress fusion with vacuoles bearing 0-layer mutations 
after the formation of these mismatches complexes [41]. In our experiments, curiously, the 
increase in SNARE complexes observed with SNARE overexpression vacuoles did not correlate 
with an increase in the concentration of associated HOPS complex, suggesting that the excess 
SNARE complexes bypass the requirement for the HOPS complex and the proofreading 
mechanism.  
 
Our data thus far has indicated that the physical state (e.g. curvature and lateral tension) 
of the membrane regulates the efficiency of the SNARE-mediated hemifusion-fusion transition. 
This suggests that the membrane determines the activation energy level that SNARE-induced 
force is required to reach to stimulate fusion. It is widely accepted that the formation of the 
helical SNARE bundle pulls and distorts the apposed membranes together to activate fusion. 
Here the energy generated from the formation of the SNARE complexes is transmitted to the 
membrane through the TMDs at the point of contact between the bilayers. Previous work by 
others has shown that the TMD of the vacuolar SNARE Vam3p is essential for productive 
priming and supporting fusion [31]. Also, cells carrying a GPI anchored hemagglutinin (HA) 
were stalled in the hemifusion stage and could not achieve complete fusion with red blood cells. 
The defect in fusion has been attributed to the absence of a TMD and the fact that the GPI anchor 
only traverses the outer leaflet of the bilayer [42-44]. Although the sequence is not as critical, 
there is a stringent requirement on the length of the TMD to achieve full functionality. 
Truncation mutants in the TMD of HA revealed a strict requirement of at least 17 amino acids to 
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successfully effect fusion. TMDs smaller than the critical length could not span the entire length 
of the bilayer and were stalled at the hemifusion stage [45]. On the other hand, increase in the 
separation between the coiled-coil and the transmembrane domain (by insertion of a flexible 
linker) also drastically reduced fusion, possibly by relieving the strain generated on the 
membrane [46]. 
 
The alpha-helical TMD of Vam3p was replaced with the isoprenylation sequence 
(CCIIM) of Ykt6p to make Vam3p-CCIIM. The lipid-anchored form of Vam3p-CCIIM is 
inserted into the vacuole and is present at levels similar to wild type Vam3p. Vam3p-CCIIM 
vacuoles accumulate cis- and trans-SNARE complexes indicating that Sec18pp-dependent 
priming is attenuated and that trans-SNARE pairs are non-productive resulting in nearly an 80% 
reduction in fusion relative to wild type [31]. We hypothesize that Vam3p-CCIIM fails to 
function due to a break in energy transfer between the SNARE complex and the membrane. 
Thus, it is likely that this mutant SNARE complex cannot transfer sufficient energy to reach the 
activation energy needed for hemifusion-fusion transition. This may be due to the shortened span 
of the lipid anchor, which only crosses one leaflet of the bilayer. Another possibility is that the 
specific interactions between the TMD of Vam3p and certain lipids in the bilayer are abolished 
leading to reduced fusion. Furthermore, the defective priming seen with this mutation is likely 
due to the inability of Sec17p and Sec18pp to correctly disrupt the cis-SNARE complex, 
suggesting that Vam3p-CCIIM complexes may adopt an altered conformation compared to wild 
type complexes.  
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Because membrane fusion requires the generation of a specific activation energy to drive 
lipid rearrangement during the hemifusion-fusion transition, we hypothesized that lowering the 
activation energy would stimulate fusion of Vam3p-CCIIM containing vacuoles as well. To this 
aim, we used CPZ to lower the energy barrier and help catalyze fusion. We used vacuoles from 
DKY6281 and BJ3505 strains that produced Vam3p-CCIIM in standard fusion assays. In Fig. 
2.4A we show that treatment with CPZ led to a greater than two-fold increase in fusion relative 
to the untreated control. This is also in accord with the idea that CPZ lowered the activation 
energy of fusion to a level that matched the force generated by Vam3p-CCIIM. This supports the 
idea that the membrane regulates SNARE mediated fusion. Others have shown that the 
interactions of Vam3p TMDs promote the hemifusion-fusion transition [47]. Thus, we posited 
that replacing the TMD of Vam3p with a lipid anchor would also lead to an arrest at the 
hemifusion-fusion state. To examine this we examined the ability of Vam3p-CCIIM to stimulate 
hemifusion using the aforementioned lipid-mixing assay and found that Vam3p-CCIIM vacuoles 
reached hemifusion similar to what was observed with WT vacuoles (Fig. 2.4B-C). As a control, 
we used reactions that were inhibited with antibody against Vam3p or a mixture of Gyp1-56p 
and GDI to inhibit Ypt7p function.  Thus, the lack of a TMD inhibits the hemifusion-fusion 
transition.  
 
Next, we performed Vam7p bypass experiments using two combinations of vacuoles. 
One combination contained wild type and Vam3p-CCIIM vacuoles at a 1:1 ratio, where the 
DKY6281 reporter strain contained wild type Vam3p and the BJ3505 reporter strain harbored 
Vam3p-CCIIM (Fig. 2.5A). The second combination used both reporter strains that harbored 
Vam3p-CCIIM (Fig. 2.5B). When we tested the effect of adding exogenous Vam7p, we found 
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that this SNARE was unable to activate fusion using either vacuole combination. However, 
fusion was activated when vacuoles were treated with CPZ. Here, Vam7p
Q283R
 was also able to 
stimulate fusion in the presence of CPZ, albeit less efficiently that wild type Vam7p. 
Importantly, no combination of Vam7p and CPZ was able to stimulate fusion when both vacuole 
partners contained Vam3p-CCIIM (Fig. 2.5B).  
 
It should be noted that the vacuoles carrying the Vam3p-CCIIM mutation accumulate cis-
SNARE complexes due to a defect in priming and require the addition of exogenous Sec18pp for 
efficient disassembly [31]. An alternative explanation for Fig 2.5B could be construed based on 
the fact that in these mutants, a higher proportion of SNAREs are stuck in the cis-SNARE 
configuration thus resulting in fewer free SNAREs available for trans-SNARE complex 
formation during the Vam7p bypass reaction. If this were true, the reduced numbers of free 
SNAREs available for trans pairing, on either or both of the fusing partners would serve as the 
limiting factor for fusion and we would expect to see identical fusion profiles for Vam7p bypass 
reactions in the presence of CPZ with both the mixed (WT fused with Vam3p-CCIIM) and the 
pure Vam3p-CCIIM populations of vacuoles. We reason that the trans-SNARE complexes 
formed in 2.5A and 2.5B are equivalent in numbers and only differ in the presence or absence of 
at least one functional TMD. This difference is reflected in their ability to respond to CPZ 
treatment. Thus, we rule out priming defect as an explanation for the above observation and 
conclude that CPZ enhances fusion with a mutant Vam3p defective in transmitting force to the 
bilayer. 
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Collectively, these data suggest that the correct SNARE complex conformation together 
with the TMD act to transmit the force generated by the SNARE complex to the lipid bilayer. 
This force could be used to generate the activation energy required for lipid rearrangement to 
complete fusion. The incorrect SNARE conformation or the absence of a TMD result in 
insufficient force transmitted to the membrane and hence an inability to progress to complete 
fusion from hemifusion. Again, CPZ helps promote the hemifusion-fusion transition, but is 
unable to do so in the absence of a TMD to transmit the force to the membrane.  
 
Thus far, our data corroborates the hypothesis that the physical properties of membranes 
regulate fusion via the TMDs of SNAREs. In native biologically active membranes, the physical 
properties of the bilayer are controlled by the lipid composition and the lateral segregation of 
microdomains where regulatory lipids and SNAREs interdependently assemble to promote 
fusion [16]. These regulatory lipids are likely to control the local curvature and fluidity at the site 
of fusion. In vacuoles, the fusion machinery is gathered into membrane rafts regulated by a small 
group of chemically important lipids that include DAG, PA, ergosterol, and a panel of 
phosphoinositides. Here we tested whether regulatory lipids controlled trans-SNARE complex 
formation and interactions with the HOPS tethering complex. We used well-characterized lipid-
binding ligands to specifically bind and sequester lipids. PtdIns(3)P was ligated with either 
FYVE or PX domains. The Ent3p-ENTH domain was used to bind PtdIns(3,5)P2. PtdIns(4,5)P2 
was either bound with the Epsin 1 ENTH domain or converted to PtdIns(4)P with the bacterial 
PtdIns phosphatase SigD. FappPH was used to bind PtdIns(4)P. DAG was bound with C1b, and 
ergosterol was bound by the polyene macrolide filipin. To isolate trans-SNARE complexes, we 
performed fusion assays using vacuoles isolated from yeast that lacked Nyv1p and expressed 
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Vam3p containing an internal calmodulin-binding peptide (CBP) (CBP-Vam3p nyv1), which 
were incubated with DKY6281 vacuoles (VAM3 NYV1) [48]. This ensured that the observed 
CBP-Vam3p-Nyv1p complexes were formed in trans. Following incubation CBP-Vam3p protein 
complexes were affinity isolated with calmodulin agarose and analyzed by immunoblotting. All 
of the ligands and phosphatases used resulted in potent fusion inhibition (Fig. 2.6A), consistent 
with previous reports [12,16,49]. The inhibition of fusion by Ent3p-ENTH is novel and suggests 
that PtdIns(3,5)P2 plays an important role in vacuole fusion [50].  
 
Through these experiments we found that regulatory lipids had distinct roles in the 
formation of trans-SNARE complexes as well as their interactions with the HOPS complex. We 
found that interaction of CBP-Vam3p with Nyv1p was most sensitive to FYVE, PX, and 
FappPH, illustrating that PtdIns(3)P and PtdIns(4)P were crucial for trans-SNARE pairing (Fig. 
2.6B), in accord with findings reported by Collins and Wickner [48]. We also found that C1b and 
filipin reduced the pairing of CBP-Vam3p and Nyv1p, demonstrating that DAG and ergosterol 
were also required for optimal complex formation. The PX domain blocked fusion and reduced 
CBP-Vam3p-Nyv1p interaction, yet had no effect on Vam7p incorporation into the remaining 
complex. The effect on fusion was likely due to the binding of PtdIns(3)P and HOPS complex by 
the Vam7p PX domain [12,49]. Surprisingly, blocking PtdIns(4)P with FappPH had a striking 
effect on Vam7p incorporation into SNARE complexes while the total Vam7p associated with 
the membrane was unaffected (not shown). This suggests that PtdIns(4)P was important for the 
stabilization of the 3Q SNARE complex. Although Ent3p-ENTH potently inhibited fusion (Fig. 
2.6A), it had no effect on trans-SNARE complex formation indicating that PtdIns(3,5)P2 
regulated fusion either downstream of docking or in a parallel pathway. The exact mechanism of 
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inhibition by Ent3p-ENTH remains uncertain. Others have found that the Ent3p-ENTH domain 
interacts with the N-terminal domains of Vti1p, Pep12p and Syn8p where it promotes the fusion 
of late endosomes [51,52]. Thus, the inhibitory nature of this domain on vacuole fusion is likely 
not due to SNARE binding but rather to its ability to bind PtdIns(3,5)P2 [50]. The role of 
PtdIns(4,5)P2 was examined using the Epsin1-ENTH domain and the bacterial phosphatase 
SigD. We found that each reduced trans-SNARE pairing and HOPS binding to the complex. C1b 
and filipin both reduced Nyv1p-Vam3p interaction and blocked the incorporation of Vam7p into 
SNARE complexes demonstrating that DAG and ergosterol control the formation of Vam7p-
containing trans-SNARE complexes. This also suggests that Nyv1p does not require a complete 
3Q-SNARE bundle to interact with Vam3p. This is keeping with a recent report showing the 
existence of an alternative pathway in trans-SNARE complex formation [53]. Other reports have 
shown that blocking DAG with C1b has no effect on bulk association of Vam7p with the 
membrane [16], suggesting that DAG is directly required in the stabilization of the 3Q-SNARE 
complex and subsequent trans complex. Curiously, treating vacuoles with C1b also caused an 
upward mobility shift in Vps33p; however, it is unclear whether protein modification occurred.  
 
Regarding the role of regulatory lipids and the association of HOPS with SNARE 
complexes, we must integrate our results with previous studies investigating the overall binding 
of HOPS to vacuoles. Previous studies have shown that both Vam7p and HOPS can dissociate 
from vacuoles when treated with specific lipid binding ligands. One study showed that HOPS 
was released from membranes when vacuoles were treated with FYVE, FappPH or Epsin1-
ENTH, indicating that PtdIns(3)P, PtdIns(4)P, and PtdIns(4,5)P2, respectively aid in retaining the 
tethering complex on the vacuole [49]. This is in keeping with our data showing that FYVE, 
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FappPH and Epsin1-ENTH reduced the amount of Vps33p associated with CBP-Vam3p protein 
complexes. Thus, the reduction of HOPS associated with SNARE complexes may be due to the 
overall loss of HOPS from the membrane. However, it is unclear whether HOPS or Vam7p 
continue to bind phosphoinositides after trans-SNARE complex assembly. It is not known 
whether the membrane association of HOPS is affected by ligands that target other regulatory 
lipids. The reduction of Vam7p in trans-SNARE complexes is also likely to be affected by the 
overall level of Vam7p present on membranes treated with lipid binding ligands. Previously, we 
showed that Vam7p was released from vacuole membranes when regulatory lipids were blocked 
with ligands that targeted PtdIns(3)P, PtdIns(4,5)P2, and ergosterol [16].  
 
Because some lipids function in fusion before SNARE complex formation while others 
function downstream, we next examined whether a block on the early acting lipids could be 
bypassed by adding soluble Vam7p. Fusion reactions were blocked with different lipid ligands 
and subsequently treated with exogenously added soluble Vam7p. In Figure 2.7A we show that 
Vam7p rescued fusion reactions where PtdIns(3)P was blocked with PX, but not FYVE domain. 
This is likely due to the direct competition between PX and full length Vam7p. We also found 
that Vam7p could partially bypass blocks mediated by SigD, Epsin1-ENTH and FappPH. These 
data suggest that PtdIns(3)P, PtdIns(4)P, and PtdIns(4,5)P2 function upstream of Vam7p. In 
contrast, Vam7p was unable to bypass blocks by C1b and filipin, suggesting that DAG and 
ergosterol, respectively function downstream or in parallel to Vam7p. We next examined if 
modulating membrane curvature and fluidity could enhance the Vam7p bypass of lipid ligand 
inhibition. To this end we tested whether CPZ could aid Vam7p bypass of four different lipid 
ligands (Fig. 2.7B). We found that fusion blocked by FYVE or filipin were not affected by the 
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addition of CPZ. In contrast, CPZ enhanced the bypass of a PX block. Importantly, CPZ allowed 
Vam7p to bypass a C1b block. Because C1b prevents the function of DAG, which induces 
negative curvature and destabilizes lipid bilayers [54,55], it is possible that the effect of CPZ 
could overcome the effect of DAG by promoting negative curvature and lowering the energy 
barrier at the site of fusion. Together these data indicate that different regulatory lipids operate 
upstream and downstream of Vam7p. It also illustrates that some of the lipids that act 
downstream of Vam7p (e.g DAG) could have an important role in maintaining the curvature of 
the membrane during fusion. 
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DISCUSSION 
 
In this study we examined the role of the lipid bilayer in the regulation of SNARE-
mediated fusion. The effects of lipid composition and the physical properties of membranes on 
SNARE function have been largely overlooked. The lipid bilayer exerts two major influences on 
membrane-spanning proteins at a non-bonding chemical level, and non-specific interactions that 
occur at a physical level. In terms of physical effects, the bilayer can serve as a regulator of 
membrane-spanning proteins, where protein function can be affected by numerous parameters 
including bilayer thickness, fluidity, curvature, acyl chain packing, lateral compression, 
hydrophobic mismatching, and line tension [27]. Membrane thickness itself can be modulated by 
sterol content as well as acyl chain length, and can have profound effects on protein function. 
Membrane raft microdomains are enriched in cholesterol/ergosterol and sphingolipids that phase 
separate from the bulk of the membrane [56]. We hypothesize that the core fusion machinery is 
controlled by the local physical state of the vacuolar membrane. This concept is consistent with 
studies showing that SNARE proteins are often found in clusters in cholesterol-rich membrane 
rafts as shown by microscopy, and isolation of detergent resistant rafts [57]. Moreover, a 
growing number of studies have shown that specific lipids that influence the physical properties 
of membranes regulate SNARE-dependent fusion, including omega-3 docosahexaenoic acid 
[58], sphingosine [59], cholesterol [60-62], phosphoinositides [12,16,23,63,64], DAG [21], and 
PA [25,65]. 
 
SNARE-mediated fusion occurs when the formation of four alpha-helical coiled-coils 
release free energy. The energy is transferred through the membrane-proximal linkers and into 
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the TMD domains, which then deform and destabilize the bilayer to surpass the activation energy 
threshold required for fusion. When SNARE complexes are mutated such that the canonical 
3Q:1R ratio is changed (e.g. 2Q:2R), membrane fusion is attenuated. We surmise that the mutant 
SNARE complex exerts insufficient force on the membrane leading to fusion stalled at the 
hemifusion stage [30]. We further tested this hypothesis by examining SNARE complexes where 
one TMD is exchanged for a lipid anchor (e.g. Vam3p-CCIIM) [29,31]. Here we showed that 
matching the energy barrier needed to stimulate lipid mixing with the energy released by the 
SNARE bundle could activate otherwise non-functional SNARE complexes. One method used in 
this study was the chemical treatment of membranes with the cationic amphipath CPZ, which 
stimulated the hemifusion-fusion transition mediated by 2Q:2R SNARE complexes as well as 
those containing Vam3p-CCIIM. Because CPZ lowers membrane tension our results are in 
accord with the notion that lowering the activation energy threshold of lipid mixing enables 
weaker SNARE bundles to stimulate the hemifusion-fusion transition. We also augmented 
Vam7p
Q283R
-mediated fusion by increasing the copy number of SNARE complexes on the 
vacuole, suggesting that the energy generated by each mutant SNARE complex is additive in the 
bypass of the membrane energy barrier to stimulate fusion.   
 
Although we have shown that mutant SNAREs can be activated by chemically 
modulating membrane tension and curvature, it is still unclear how the assembly of the vertex 
microdomain controls SNARE mediated fusion. Lipid composition can change the local physical 
properties of the bilayer, yet the mechanisms by which these lipids regulate fusion remain 
uncertain. Regulatory lipids such as sterols and sphingolipids serve to thicken and stiffen raft 
microdomains, whereas others are essential for the recruitment and activation of soluble proteins 
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[66,67]. A third function of regulatory lipids in these microdomains is the focused destabilization 
of the bilayer. Lipids such as DAG are known to induce negative curvature and destabilize 
bilayers [54,55]. The negative curvature induced by DAG and its enrichment at the vertex ring is 
consistent with the occurrence of a hemifusion intermediate [20]. This is also in keeping with the 
stalk hypothesis of hemifusion where the fusion stalk contains negative curvature structures [68]. 
Formation of the stalk is energetically disfavored by the insertion of LPC and creation of positive 
curvature in the outer layer of the membrane. Our finding that CPZ can overcome the inhibited 
fusion caused by C1b emphasizes this importance of DAG in creating negative curvature and 
destabilizing the membrane. We posit that binding DAG with C1b inhibits the lipid from 
inducing negative curvature and that CPZ restores the negative curvature needed for fusion.  
 
The mechanism by which the membrane regulates SNAREs through a single TMD 
connecting to the SNARE motif via a short linker remains uncertain. However, new insights 
have been provided by the crystal structure of the neuronal cis-SNARE complex [69]. Several 
new aspects of SNARE interactions were revealed, including the continuity of the alpha helices. 
These helices begin in the SNARE motifs and continue undisrupted through the linkers and into 
the TMDs. With this knowledge, it is much easier to envision how changes in the membrane 
could be transferred to the SNARE motif. Furthermore, specific interactions were found between 
the TMDs of syntaxin-1 and synaptobrevin-2, suggesting that interactions between the TMDs 
could affect the conformational arrangement of the cytoplasmic domains and regulate cis-
SNARE priming. The continuity of the alpha helices coupled with the interactions of TMDs 
sheds some light on other studies showing that TMD of synatxin-1 contains residues that regulate 
its cytoplasmic interactions with SNAP-25, a lipid anchored SNARE that lacks an alpha helical 
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TMD [70], indicating that the syntaxin-1 TMD allosterically regulates the interaction of SNAP-
25 with the cytoplasmic domain of syntaxin-1. Ungermann and colleagues showed that the TMD 
of the vacuolar SNARE Vam3p is essential for productive priming and supporting fusion [31]. 
Lipid-anchored Vam3p-CCIIM vacuoles accumulate cis- and trans-SNARE complexes 
indicating that Sec18pp-dependent priming is attenuated and that trans-SNARE pairs are non-
productive resulting in a striking inhibition in fusion relative to wild type Vam3p. The lack of a 
TMD would inhibit the interactions of Vam3p-CCIIM with the TMDs of other vacuolar 
SNAREs and potentially alter the conformational structure of the cytoplasmic SNARE bundle 
and its productive interactions with the priming machinery. There is mounting evidence, 
including the results of the current study, indicating that the membrane serves as an a regulator 
of SNARE function.   
 
 One way that membranes can modulate the allosteric effects on proteins is through 
changing its physical properties, which are regulated through modifications in lipid composition. 
This is consistent with vacuole fusion as the stoichiometry of lipid species composing the vertex 
microdomains are not static. Numerous lipid modifications occur through the actions of lipid 
kinases, phosphatases, and lipases. For example, during vacuole fusion DAG is produced by 
Plc1p (phospholipase C) as well as the phosphatidic acid phosphatase Pah1p [21,25]. In addition, 
various lipid kinases produce phosphoinositides during vacuole fusion that include PtdIns(3)P, 
PtdIns(4)P, PtdIns(3,5)P2, and PtdIns(4,5)P2 [23,71]. The dephosphorylation of 
phosphoinositides has also been shown to disrupt vertex microdomains and disperse SNAREs 
from the site of fusion [16]. In addition, the genetic deletion of various phosphoinositide 
phosphatases yields abnormal vacuolar phenotypes, a hallmark of defective vacuole homeostasis. 
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Among these phosphatases is the PtdIns(3)P phosphatase Ymr1p, the synaptojanin-like 
phosphatases Sjl2p and Sjl3p, and the PtdIns(4,5)P2 5-phosphatase Inp54p [72,73]. Together, 
these reports underscore the dependence of vacuole function and lipid modification. Although 
we have yet to determine the exact roles of lipid modification on vacuole SNARE function, there 
is growing evidence that the two are integrated in the regulation of vacuole function.  
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MATERIALS AND METHODS 
Reagents 
All reagents were diluted in PS buffer (20 mM PIPES-KOH pH 6.8, 200 mM sorbitol) to a 
working concentration before use in any experiment. Antibodies against Nyv1p [74], Sec17p 
[75], Sec18pp [11], Vam3p [76] have been described previously. Chlorpromazine (Sigma) was 
stored as a 4.5 mM stock solution in DMSO. Lysophosphatidyl choline (Sigma) was stored at a 
stock concentration of 1% (wt/vol) in 100% ethanol. Filipin was dissolved in DMSO at a stock 
concentration of 10 mM and used at a final concentration of 20 M. 
 
Recombinant proteins 
Recombinant GST-Vam7p (wild type and Q283R) was purified and dialyzed into PS buffer with 
125 mM KCl as described [30,77]. The lipid binding domains GST-C1b [78], GST-FYVE [79], 
GST-PX [12], GST-Ent3p-ENTH (a gift from S. Friant, Institut de biologie et chimie des 
proteins, Lyon, FR) [50], GST-Epsin1-ENTH [80], MBP-FappPH [49], His6-MTM-1 [81], His6-
SigD [82], His6-Gyp1-56 [83], GDI [84] were purified as previously described. 
 
Strains 
BJ3505 (MAT pep4::HIS3 prb1-1.6R his3-200 lys2-801 trp1101(gal3) ura3-52 gal2 can1) 
and DKY6281 (MAT  leu2-3 leu2-112 ura3-52 his3-200 trp1-901 lys 2-801) were used for 
standard vacuole fusion assays [85]. The Vam3p-CCIIM strains carry a chimeric Vam3p where 
the transmembrane domain was replaced with the farnesylation site from Ykt6p [31]. Yeast 
strains overexpressing the four vacuolar SNAREs under the control of an ADH promoter (A gift 
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from V. Starai, University of Georgia) were used in Vam7p bypass fusion reactions [84]. BJ3505 
CBP-Vam3p nyv1 was used for isolating trans-SNARE complexes [48].  
  
Vacuole Isolation and in vitro vacuole fusion 
Vacuoles were isolated from yeast strains by floatation [86]. Fusion reactions (30 l) contained 3 
g each of vacuoles from BJ3505 (pep4∆ PHO8) and DK6281 (PEP4 pho8∆), fusion assay 
buffer (125 mM KCl, 5 mM MgCl2, 20 mM PIPES-KOH pH 6.8, 200 mM sorbitol), ATP 
regenerating system (1 mM ATP, 29 mM creatine phosphate, 0.1 mg/ml creatine kinase), 10 M 
CoA and 283 nM IB2. Reactions were incubated at 27C for 90 minutes and the Pho8p activity 
was measured in 250 mM Tris-Cl PH 8.5, 0.4% Triton X-100, 10 mM MgCl2, 1 mM p-
nitrophenylphosphate. During fusion, the Pep4p protease gains access to the pro-alkaline 
phosphatase (proPho8p) and cleaves it to form mature alkaline phosphatase. The quantity of p-
nitrophenylate produced was measured at 400 nm. One unit of fusion was defined as 1 mol of 
p-nitrophenylate produced minute
-1
 g-1 of pep4 vacuoles. 
 
Vam7p bypass fusion reaction 
Fusion reactions were incubated at 27C with 85 g/ml -Sec17 antibody to block priming. 
After 15 minutes, 150 M chlorpromazine (CPZ) or 0.033% lysophosphatidylcholine (LPC) was 
added and the reactions were incubated for 5 minutes before the addition of Vam7p or 
Vam7p
Q283R
. The reactions were incubated for an additional 70 minutes and assayed for alkaline 
phosphatase activity. 
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Trans-SNARE complex Isolation 
Trans-SNARE complexes were isolated and analyzed as described with some minor 
modifications [48,87]. Large-scale 16X (480 l) fusion reactions containing 48 g of vacuoles 
from BJ3505 CBP-Vam3p nyv1 and 48 g of vacuoles from DK6281 backgrounds were 
incubated in the presence of buffer or different lipid binding domains (10 M Ent3p-ENTH, 10 
M GST-Epsin1-ENTH, 25 M GST-PX, 2 M His6-SigD, 1 M MBP-FappPH, 20 M Filipin, 
10 M GST-C1b or 2 M GST-FYVE). After incubation at 27C for 90 minutes, reactions were 
placed on ice for 5 minutes and 30 l was withdrawn from each sample to assay Pho8p activity. 
The remaining samples were centrifuged (16,000 g, 15 minutes, 4C) to sediment the vacuoles 
and the supernatants were discarded. Vacuole pellets were overlaid with 200 l ice-cold 
solubilization buffer (20 mM Tris-Cl pH 7.5, 150 mM NaCl, 1 mM MgCl2, 0.5% Triton X-100 
and 20% glycerol) with protease inhibitors (0.46 g/ml leupeptin, 3.5 g/ml pepstatin, 2.4 g/ml 
Pefabloc-SC and 1 mM PMSF) and gently resuspended. Solubilization buffer was added to a 
final volume of 400 l and the extracts were mixed by nutating at 4C. After 20 minutes, 
insoluble debris was removed by centrifugation (16,000 g, 20 minutes, 4C). Supernatants were 
transferred to fresh tubes and 10% of the extract was saved for input samples. The remaining 
extracts were brought up to 2 mM CaCl2 and incubated with 40 l calmodulin Sepharose beads 
equilibrated with solubilization buffer (GE Healthcare; 4C, 12 h, nutating). The beads were 
collected by centrifugation (3,000 g, 2 minutes, 4C) and washed five times with 1 ml of 
solubilization buffer containing 1% Triton and 2 mM CaCl2 followed by bead centrifugation. 
Bound proteins were eluted with solubilization buffer containing 0.1% Triton X-100 and 5 mM 
EGTA. The eluents were mixed with SDS sample buffer and used for SDS-PAGE analysis and 
immunoblotting. 
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Lipid mixing 
Lipid mixing assays were conducted using Rhodamine conjugated phosphatidylethanolamine 
(Rh-PE; Invitrogen) as described with minor modification [25]. BJ3505 background vacuoles 
(300 g) were incubated in 400 µl of PS buffer containing 150 M Rh-PE (10 minutes, 4°C, 
nutating). Samples were mixed with 15% Ficoll in PS buffer (wt/vol) and transferred to an 
ultracentrifuge tube (11 x 60 mm). Samples were overlaid with 1.0 ml each of 8%, 4%, and 0% 
Ficoll. Labeled vacuoles were re-isolated by centrifugation (105,200 g, 25 minutes, 4°C) and 
recovered from the 0 - 4%-Ficoll interface. Lipid mixing assays (90 µl) contained 2 g of Rh-
PE-labeled vacuoles and 16 g of unlabeled vacuoles in fusion buffer. Reaction mixtures were 
transferred to a black, half-volume 96-well flat-bottom microtiter plate and Rhodamine 
fluorescence was measured using a fluorometer at 27°C.  Measurements were taken every minute 
for 60 minuntes, yielding fluorescence values at the onset (F0) and during the reaction (Ft).  The 
final 10 measurements of a sample after adding 0.33% (vol/vol) Triton X-100 were averaged and 
used as a value for the fluorescence after infinite dilution (F TX100).  The relative total 
fluorescence change Ft /FTX100 = (Ft - F0)/FTX100 was calculated.  
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FIGURES 
 
Figure 2.1. Non-canonical SNARE complexes exert insufficient force on the membrane.  
(A) Individual fusion reactions were blocked at the priming stage by treating vacuoles with 85 
g/ml anti-Sec17p antibody for 15 minutes. Recombinant Vam7p (closed circles) or Vam7pQ283R 
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(closed squares) was added to bypass the priming block. In parallel, Vam7p and Vam7p
Q283R
 
were added to reactions blocked with anti-Sec17p antibody and before treatment with CPZ. (B) 
Fusion reactions were treated with anti-Sec17p antibody in the presence or absence of CPZ. 
Next, recombinant Vam7p was added to reactions at the indicated concentrations. After 
incubation (10 minutes, 27C), membranes were pelleted (16,000 g, 10 minutes, 4C) and the 
unbound Vam7p was discarded with the supernatant. Bound Vam7p was examined by 
immunoblotting. Membranes were also probed for Ypt7p as a control for loading. (C) Fusion 
reactions were treated with anti-Sec17 antibody after which Vam7p alone (closed circles) was 
added to bypass the fusion block. In parallel, reactions were treated with CPZ either before (open 
triangles) or after addition of Vam7p (open squares). (D) Uninhibited fusion reactions were 
treated with Vam7p alone (closed circles). In parallel, reactions were treated with CPZ either 
before (open triangles) or after addition of Vam7p (open squares). (E) Lipid mixing (hemifusion) 
assays were performed using vacuoles blocked with anti-Sec17p at 4C. After 15 minutes, 400 
nM Vam7p (WT or Q283R) was added to the indicated reactions and incubated for 60 minutes at 
27C. The increase in fluorescence occurred when the outer leaflets of vacuoles were mixed 
during hemifusion. Shown is a representative of 3 trials. (F) Shown is the average lipid 
dequenching at 60 minutes. Error bars indicate SEM (n=3). 
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Figure 2.2. Lysophosphatidylcholine inhibits the Vam7p bypass of anti-Sec17p IgG blocked 
fusion reactions. Fusion reactions were treated with buffer or blocked with anti-Sec17p 
antibody. Reactions were further treated with 150 M CPZ or 0.033% LPC for 5 minutes 
preceding the addition of recombinant Vam7p or Vam7p
Q283R
. In parallel, anti-Sec17p antibody 
blocked vacuoles were treated with CPZ for 5 minutes followed by LPC for 5 minutes or vice 
versa before the addition of 400 nM Vam7p or Vam7p
Q283R
. Error bars represent SEM (n=3)
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Figure 2.3. Non-canonical SNARE complexes support fusion when their surface density is 
increased. (A) Standard fusion reactions containing vacuoles from wild type strains (black bars) 
or SNARE overexpressing strains (gray bars) were blocked at the priming stage with 85 g/ml 
anti-Sec17p antibody for 15 minutes. Recombinant GST-Vam7p (400 nM, black bars) or 
Vam7p
Q283R 
(gray bars) was added to bypass the priming block. Error bars represent SEM (n=3). 
(B) GST-Vam7p protein complexes were isolated as described in the Materials and Methods 
section and examined by immunoblotting for the indicated proteins.  
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Figure 2.4. CPZ augments fusion of vacuoles containing lipid-anchored Vam3p.  
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(A) Standard fusion reactions were performed using vacuoles from DKY6281 and BJ3505 
strains harboring Vam3p-CCIIM. Fusion reactions were treated with buffer (Control) or CPZ and 
incubated for 90 minutes and fusion was measured by content mixing and Pho8p activity. (B) 
Lipid mixing (hemifusion) assays were performed using WT or Vam3p-CCIIM vacuoles as 
described in the Materials and Methods section. WT vacuoles were also treated with anti-Sec17 
to block SNARE priming. Reactions were incubated for 60 minutes at 27C. Shown is a 
representative of 3 trials. The inset represents the average lipid dequenching at 60 minutes. Error 
bars indicate SEM (n=3). (C) Shown is the average lipid dequenching at 60 minutes. Error bars 
indicate SEM (n=3). 
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Figure 2.5. CPZ and Vam7p bypass anti-Sec17p IgG-blocked fusion of vacuoles containing 
lipid-anchored Vam3p.  
(A) Vacuoles from wild type DKY6281 were incubated with BJ3505 vacuoles harboring 
Vam3p-CCIIM. Priming was blocked with anti-Sec17p antibody for 15 minutes and reactions 
were treated with 150 M CPZ for 5 minutes before the addition of 400 nM Vam7p or 
Vam7p
Q283R
. (B) Fusion reactions were performed with DKY6281 and BJ3505 vacuoles 
harboring Vam3p-CCIIM. Fusion reactions were treated with CPZ and Vam7p as described in 
(A). Error bars represent SEM (n=3). 
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Figure 2.6. Regulatory lipids control trans-SNARE complex formation and interactions 
with the HOPS complex.  
16X standard fusion reactions containing 48 g of BJ3505 CBP-Vam3p nyv1 vacuoles and 48 
g DK6281 vacuoles were treated with inhibitory concentrations of the following lipid binding 
domains: 2 M GST-FYVE, 25 M GST-PX, 1 M MBP-FappPH, 10 M Ent3p-ENTH, 10 M 
Epsin1-ENTH, 10 M GST-C1b, 2 M His6-SigD or 20 M filipin for 90 minutes at 27C. (A) 
Samples (30 l) were withdrawn from each reaction to measure Pho8p activity following fusion. 
Error bars represent SEM (n=3). (B) The reaction remainders were centrifuged to isolate the 
vacuoles. Membranes were then solubilized and CBP-Vam3p complexes were affinity purified 
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Figure 2.7. Vam7p and CPZ can bypass fusion blocked by specific lipid ligands.  
(A) Fusion reactions were treated for 5 minutes with lipid binding domains including GST-
FYVE, GST-PX, GST-C1b, Filipin, His6-SigD, MBP-FappPH and Ent3p-ENTH as described in 
Fig. 5. Next, Vam7p (400 nM) was added to the reactions and incubated for a total of 90 
minutes. Fusion was tested by content mixing and Pho8p activity. (B) Fusion reactions were 
treated for 5 minutes with lipid binding domains including. Next, 150 M CPZ was added and 
the reactions were incubated for an additional 5 minutes before the addition of 400 nM Vam7p. 
Error bars represent SEM (n=3). 
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ROLE OF THE YEAST PA PHOSPHATASE Pah1p IN 
THE RECRUITMENT OF THE AAA+ ATPase Sec18p TO 
CIS-SNARE COMPLEXES DURING PRIMING 
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SUMMARY 
 
 
Yeast vacuole membrane fusion relies on a set of regulatory lipids and lipid modifying enzymes. 
One such enzyme (Pah1p) controls the dephosphorylation of phosphatidic acid (PA) to yield 
diacylglycerol (DAG). Here, we examined the role of Pah1p in the priming stage of fusion. 
Specifically, we found Pah1p as the factor responsible for recruitment of Sec18p, a AAA+ 
ATPase that diassembles cis-SNARE complexes during priming. We demonstrate a direct 
interaction between Sec18p and the lipid phosphatidic acid. This interaction was dictated by the 
nucleotide bound state of Sec18p. ADP bound population of Sec18p was primarily found 
associated with phosphatidic acid, whereas the ATP-bound active configuration of Sec18p bound 
the cis-SNARE complexes. We also show Pah1p as the factor that triggers a switch from inactive 
phosphatidic acid-bound Sec18p to the active cis-SNARE bound Sec18p during priming in yeast 
vacuole membrane fusion. These findings demonstrate that modifying the lipid composition of 
the membrane can be an important trigger for recruitment of fusion factors. 
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INTRODUCTION 
 
Membrane fusion involves the fusion of two distinct lipid bilayers into a continuous membrane 
followed by mixing of the lumenal contents. Biological membrane fusion is an underlying 
recurrent theme in a variety of cellular processes including endocytosis, neurotransmission, 
antigen presentation and cargo sorting (1-3). The basic scheme of lipid bilayer fusion is 
conserved throughout  eukaryotes (4) and requires regulatory lipids and conserved proteins like 
the GTPases of the Rab/Ypt family, NSF/Sec18p ATPase and its co-chaperone -SNAP/Sec17p 
and the essential protein fusion machinery called the SNAREs (soluble NSF attachment protein 
receptors (5). 
 
 Yeast homotypic vacuole fusion is an exemplary model to study membrane fusion and is 
characterized by a series of experimentally distinct, well-defined phases. The fusion cascade is 
initiated when the AAA+ protein Sec18pp (NSF) and Sec17p (-SNAP) disassemble 
unproductive cis-SNARE complexes during priming (5,6). Disruption of cis-SNARE complexes 
leads to the dissociation of Sec17p as well as the soluble SNARE Vam7p (7,8).  In the next 
stages of tethering and docking, primed vacuoles become reversibly docked through the function 
of the Rab family GTPase Ypt7p and its effector complex HOPS (9). The activity of Ypt7p is 
regulated by its cognate nucleotide exchange factor Mon1p and the GTPase activating factor 
Gyp7p. During the docking stage Vam7p rebinds through its interactions with the hetero-
hexameric tethering complex HOPS and the lipid phosphatidylinositol 3-phosphate (PI3P), and 
enters a trans-SNARE complex (10). The Sec/Munc proteins play a vital role ensuring the 
correctness of the trans-SNARE complexes (11). Vacuole fusion occurs at highly organized 
membrane rafts termed vertex microdomains that form at the point of contact between partner 
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vacuoles, and become enriched in the lipids and proteins required for fusion (12,13). The 
formation of the trans-SNARE complexes triggers the release of Ca
2+
 from the vacuole lumen 
(14). The penultimate step in fusion is a hemifusion intermediate where the closely apposed 
outer membrane leaflets fuse without fusing the inner leaflets (15). The fusion pathway 
culminates with the fusion of inner leaflets and content mixing.  
 
The interplay of interaction between fusion proteins and lipids is a cornerstone in the 
progression and regulation of membrane fusion. The lipids could serve two functions; they could 
serve as a scaffold for the binding and recruitment of various protein factors. This function 
depends on the direct chemical interaction of lipids with the protein fusion catalysts, which is 
exemplified by the interaction of the Vam7p PX domain with PI(3)P (16).The second mechanism 
is indirect and physical (17). This is demonstrated by the dependence of SNARE function on the 
assembly of metabolically active membrane raft microdomains (12). The assembly of ergosterol-
rich microdomains affects the local microviscosity of the membrane and can potentially exert 
allosteric effects on the transmembrane domains (TMDs) of Vam3p, Vti1p, and Nyv1p. The 
concentration of specific lipids into small domains, which may increase avidity, also regulates 
direct protein-lipid interactions and the dynamics of vacuole associated actin (12,18). 
 
The interconversion of regulatory lipids is catalyzed by various lipid modifying enzymes. 
A recent study focused on a certain lipid metabolic pathway that leads to the generation of DAG 
from PA by the action of a PA phosphatase enzyme Pah1p (19). Both PA and DAG are lipids 
essential for membrane fusion and play a vital role in various stages of fusion. DAG has been 
reported to be involved in Golgi to ER transport and the generation of COPI vesicles (20). 
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Elevated levels of PA have been reported to be essential for sporulation and stimulates fusion 
with a Q-SNARE Spo20 (21,22). Among the three major PA phosphatases present in yeast, 
neither Lpp1p or Dpp1p are implicated in vacuole fusion. However, deletion of Pah1p resulted in 
severe vacuole fragmentation which upon further investigation revealed two major defects in the 
vacuole fusion machinery: a defect in priming and protein sorting to the vacuole. PAHI deleted 
vacuoles were characterized by a failure in Sec17p release and drastically reduced levels of the  
Sec18p, a AAA+ ATPase responsible for cis-SNARE disassembly, at the site of priming (19). In 
this study, we delve deeper into the mechanism of Pah1p action during priming. We report that 
like its mammalian homologue NSF, Sec18p also binds PA. This binding was specific and could 
be blocked by PA specific binding domain TGD2. Sec18p interaction with PA was also 
dependent on its nucleotide bound state. We found two distinct populations of Sec18p based on 
its nucleotide bound state: ADP bound Sec18p predominantly bound PA on the membrane and 
the ATP bound state predominantly bound cis-SNARE complexes.  Based on these observations 
we hypothesize that Sec18p is held on the membrane at PA rich domains prior to the start of 
fusion. During priming, following the conversion of PA to DAG by Pah1p, Sec18p falls off the 
PA rich domain and is recruited to the cis-SNARE complexes. Thus, we conclude that Pah1p 
plays an important role in recruiting Sec18p to the cis-SNARE complexes during priming 
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RESULTS 
 
In an earlier study from our group (19), we uncovered a role for the yeast homologue of 
Lipin1 (Pah1p) in the regulation of membrane fusion. We used propranolol, a known small 
molecule inhibitor of PAP activity to inhibit Pah1p and demonstrated an essential role for the 
metabolic reaction synthesizing DAG from PA in membrane fusion (31,32). We found that 
propranolol inhibited vacuole fusion, specifically in the priming stage. Vacuoles treated with 
propranolol were defective in priming and Sec17p release during priming (Fig 3.1). PAHI 
deleted vacuoles also showed low levels of Sec18p bound to cis-SNARE complexes during 
priming (data not shown). Together, these observations underline a role for Pah1p during 
priming but the exact mechanism involved is yet to be unraveled. 
 
The mammalian homologue of Sec18p (NSF) is a well studied AAA+ ATPase protein 
and its interaction with PA  has been the crux of a few studies so far. NSF binds to PA and this 
binding is dependent on its ATPase activity and the nucleotide bound state of NSF. NEM inhibits 
the ATPase activity of NSF and locks it in a predominantly PA bound state. Whereas, the ATP- 
bound form of NSF displays reduced binding to phosphatidic acid (33). Drawing parallels from 
earlier NSF studies and weighing in our own findings from the Pah1p inhibition studies, we posit 
that Sec18p could also bind phosphatidic acid. This binding event on the membrane might serve 
to sequester Sec18p on the membrane before priming occurs. Phosphatidic acid phophatase 
activity of Pah1p converts PA to DAG, hence releasing the bound Sec18p, which can now be 
recruited to the cis-SNARE complexes to effect priming. 
 
70 
 
Our model requires a demonstration of interaction between PA and Sec18p. To test if 
Sec18p can bind to PA, we first performed a protein lipid overlay assay. Increasing amounts of 
the two lipids, PA or DAG were spotted on Hybond-C membrane and the lipid strips were 
incubated with purified recombinant Sec18p. The extent of bound Sec18p protein was visualized 
by western blotting using an antibody against Sec18p. Sec18p exhibited binding to PA in the 
protein-lipid overlay assay (Fig 3.2A). Surprisingly, Sec18p also bound equally well to DAG.  
Neither Sec18p nor the antibodies used for western blotting bound non-specifically to the 
membrane (Fig 3.2A lane 1). As a positive control, we also incubated the lipid strips with 
recombinant TGD2, a PA specific binding domain (24,25) and observed specific binding 
between TGD2 and PA. Thus, we conclude that Sec18p interacts with both PA and DAG and 
this interaction is specific 
 
           To further confirm our results from the protein-lipid overlay assays, we performed 
liposome association assays. Recombinant Sec18p was incubated with liposomes made from 
lipid mixtures of the four different lipids phophatidylcholine, phosphatidylethanolamine, PA 
and DAG. Liposome-bound Sec18p was separated from the unbound protein by density 
gradient centrifugation followed by western blotting to probe for the bound Sec18p. Sec18p 
did not bind to PC/PE alone liposomes.However, the presence of either PA or DAG was 
enough to solicit Sec18p interaction (Fig 3.2B). It is also important to note that the presence of 
phosphatidylethanolamine in the lipid mixture did not have any significant effect of Sec18p 
binding (Fig 3.2B; comparing lane 2 to 3 and 4 to 5). As seen before, Sec18p bound equally 
well to liposomes containing either PA or DAG. This observation is in agreement with the 
results from the protein-lipid overlay assays and once again demonstrates a direct interaction 
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between Sec18p and PA. Next, we tested whether the binding of Sec18p to either lipids PA or 
DAG was affected by the membrane lipid composition.  To this effect, we made liposomes 
containing increasing mole percentages of either PA or DAG. The concentration of the bulk 
lipid  phosphatidylcholine was maintained at 60 mole percent and the concentration of 
phosphatidylethanolamine and PA or DAG was varied to account for the rest of the 40 percent. 
There was steady increase in Sec18p associated with the liposomes when we increased the 
mole percent of phophatidic acid in the lipid mixture from 5% to 20% (Fig 3.2C).  
Surprisingly, increasing the mole percent of DAG in the lipid mixture resulted in reduced 
Sec18p binding. We had not observed this inverse relationship between Sec18p binding and 
the concentration of DAG in previous protein-lipid overlay assays. We reason that the 
liposomes were prepared with a mixture of lipids as opposed to pure lipids such as ones used in 
the protein-lipid overlay assays and this difference could account for the observed disparity in 
results. Also, with liposomes factors such as curvature and fluidity come into play, which are 
non-existent in lipid arrays such as the ones used in protein-lipid overlay assays. DAG has 
been reported to induce negative curvature in membranes (34,35). It is also possible that 
increasing the DAG concentration in these liposomes increases negative curvature such that it 
affects Sec18p binding.  
 
Next, to ascertain the specificity of Sec18p binding to either of the lipids, we performed a 
competition binding assay. The liposome association assay was modified, wherein the liposomes 
containing PA or DAG were incubated first with a PA binding protein domain TGD2 or DAG 
binding domain C1b. Following which, Sec18p binding was analyzed as described above. As 
reported earlier, Sec18p binds to liposomes containing either PA or DAG but not to PC/PE alone 
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liposomes. Blocking either PA or DAG in these liposomes resulted in abolishment of the 
Sec18p-lipid interaction (Fig 3.2D). Based on the data above, we conclude that Sec18p does 
indeed bind both PA and DAG on membranes. This interaction is specific to the lipids and 
dependent on the lipid composition of the membrane.  
 
NSF, the mammalian homologue of Sec18p has been reported to bind PA. This binding 
was found to be dependent on the nucleotide bound state of NSF. By manipulating the nucleotide 
state of NSF, the authors found that the inactive ADP bound form of NSF predominantly 
interacted with phophatidic acid, but the active ATP bound form did not (33). Since, in our 
experiments Sec18p exhibited specific binding to PA; we asked if this interaction could also be 
dependent on the nucleotide bound state of the AAA+ ATPase Sec18p. We used the following 
reagents to manipulate the nucleotide state of Sec18p: N-ethylmaleimide (NEM) is known to 
alkylate NSF and inhibit its ATPase activity, MgCl2 to stablise the ATP bound form of Sec18p 
and slowly-hydrolysable ATPγS to lock Sec18p in the ATP bound state. We also used 
propranolol to inhibit Pah1p activity and hence alter the ratio of PA to DAG on the membrane 
and study the effect membrane lipid composition on Sec18p binding. As NEM has not been 
characterized in the context of yeast vacuole membrane fusion, we started out by testing it in a 
standard fusion reaction. NEM potently inhibited vacuole membrane fusion at concentrations as 
low as 1 mM (Fig 3.3A). Based on the inhibition curve we chose 3 mM as an effective inhibitory 
concentration of NEM to use in all our future experiments  
 
Since Sec18p is a homologue of NSF and NEM inhibits the ATPase activity of NSF, we 
asked if NEM could also inhibit the ATPase activity of Sec18p. A previous study comparing the 
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effects of NEM on NSF and Sec18p reported that 3 mM NEM inhibits the ATPase activity of 
NSF but Sec18p remained insensitive to inhibition by NEM (Morgan et al;  Biochemistry 1999). 
We also performed ATPase activity assays on Sec18p in the presence of NEM and did not 
observe any significant inhibition (data not shown). It is really interesting to note that NEM 
doesnot inhibit Sec18p ATPase activity but is effective in inhibiting membrane fusion (Fig 3.3). 
To further characterize the mechanism of inhibition by NEM, we performed fusion assays to 
measure the extent of resistance gained towards different inhibitors in a standard fusion reaction. 
Inhibitory concentrations of propranolol, NEM and Vam3p IgG were added to standard fusion 
reactions at specified times after the start of fusion. Reactions were also placed on ice at these 
indicated times to stop fusion. Fusion reactions gain resistance early to inhibitors that act early in 
the fusion pathway but remain sensitive longer to reagents that inhibit the later stages in fusion. 
This assay gives a good indication of the time frame within which a reagent or protein acts 
during fusion. Fusion reactions gained resistance to propranolol and NEM as early as 10 minutes 
but remained sensitive to Vam3p IgG inhibition indicating that both propranolol and NEM 
inhibit an early stage but Vam3p IgG inhibits a late stage of fusion (Fig 3.3B). An earlier report 
also demonstrated a similar inhibition kinetics for propranolol and confirmed that it does infact 
inhibit the priming stage (19). Since, the inhibition kinetics for NEM overlaps well with that for 
propranolol, we conclude that NEM should also act at the priming stage of fusion although, the 
mechanism of inhibition still remains to be elucidated. 
 
We next used the effective concentrations of all the above mentioned reagents in a 
standard fusion assay. As expected, 2 mM Propranolol and 3 mM NEM abolished fusion 
presumably by inhibiting priming (Fig 3.3C). MgCl2 at a concentration of 2 mM was expected to 
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stabilize the ATP bound form of Sec18p and hence activate priming which is reflected in fusion 
values as high as the positive control. ATPγS is a slowly-hydrolysable form of ATP and hence 
would lock Sec18p in the ATP bound form and inhibit nucleotide exchange. Interestingly, the 
inhibition observed with ATPγS was only partial. We attribute this observation to the fact that 
purified vacuoles already carry all the components required for an active fusion. It is possible 
that a fraction of Sec18p on these purified vacuoles is already bound to ATP which accounts for 
the residual Sec18p activity and hence fusion even in the presence of ATPγS. 
 
We next asked, if like NSF, altering the nucleotide bound state of Sec18p could also 
affect its interaction with PA. We performed the aforementioned liposome association assay 
using PC/PE liposomes containing 20 mole percent PA. The Sec18p-liposome binding assay was 
slightly modified, wherein, Sec18p was first incubated with one of following reagents, 2 mM 
propranolol, 3 mM NEM, 2 mM MgCl2 or ATPγS for 30 minutes before binding PA containing 
liposomes. Propranolol treatment or NEM treatment did not affect Sec18p binding to PA 
liposomes (Fig 3.3D). We reason that since the target of propranolol inhibition, Pah1p, was not 
present in the liposomes and NEM has no effect on the ATPase activity of Sec18p, it is expected 
that neither treatments would not affect Sec18p-PA binding. MgCl2 and ATPγS treatment on the 
other hand, reduced Sec18p binding to PA marginally. It should be noted that in an earlier report, 
similar treatment of NSF MgCl2 and ATPγS also reduced NSF-phophatidic acid binding. Based 
on these data, we conclude that the ATP bound form of Sec18p, which is also the active pool of 
Sec18p, displays reduced binding to PA on membranes and hence that the nucleotide bound state 
of Sec18p dictates its interaction with PA. 
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Sec18p is an AAA ATPase and serves to disassemble cis-SNARE complexes during 
priming. We next asked if modifying the nucleotide bound state and hence the ATPase activity 
of Sec18p would affect its function during priming. To answer this question, we isolated cis-
SNARE complexes during the first 10 minutes of fusion and analyzed Sec18p associated with 
these complexes. Fusion reactions were stopped after the first 10 minutes of fusion, allowing 
fusion to proceed only to the priming stage and hence ensuring that the SNARE complexes 
isolated would predominantly be in the cis configuration. We analyzed the Sec18p associated 
with cis-SNARE complexes at the start (0 minutes) and at the end of the priming (10 minutes) 
following treatment with one of the following reagents: 2 mM propranolol, 3 mM NEM, 2 mM 
MgCl2 or ATPγs. Inhibition of Pah1p activity with propranolol, resulted in a loss of Sec18p 
associated with the SNARE complex (Fig 3.4A) indicating that Pah1p activity was required for 
the recruitment of Sec18p to cis-SNARE complexes during priming. Based on the data so far, 
this can be explained as follows; the inhibition of Pah1p activity and hence the inhibition of PA 
to DAG conversion results in more Sec18p locked in the PA bound pool and hence less of it is 
available to be recruited to the cis-SNARE complexes. NEM treatment slightly reduced Sec18p 
association at the start of priming and this defect was further exaggerated by the end of 10 
minutes. Interestingly, as noted earlier, NEM treatment doesnot inhibit the ATPase activity of 
Sec18p but inhibits priming (Fig 3.3B) and also resulted in reduced Sec18p recruitment to the 
cis-SNARE complex. It is possible that NEM could alkylate Sec18p thus altering the 
conformation of the protein, which affects its ability to interact with the SNARE proteins without 
affecting its ATPase activity. As expected, both MgCl2 and ATPγS treatments resulted in 
decreased PA binding (Fig 3.3D) and increased Sec18p recruitment to the cis-SNARE 
complexes during priming (Fig 3.4A). 
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It is important to consider the possibility that the above treatments might alter membrane 
association ability or even the stability of Sec18p. To rule out this possibility, we next analyzed 
the levels of total membrane-associated Sec18p following treatment with propranolol, NEM, 
MgCl2 or ATPγS. Fusion reactions were treated with the above-mentioned reagents for 10 
minutes. The total membrane fraction was sedimented by centrifugation and probed for Sec18p 
by western blotting. None of the above treatments had any effect on the levels of membrane 
associated Sec18p (Fig 3.4B). This observation taken together with the data so far leads us to the 
conclusion that nucleotide bound state of Sec18p dictates its distribution between the ATP 
bound-cis-SNARE associated and the PA bound pools. This observation demonstrates an inverse 
relationship between PA associated and cis-SNARE associated pools of Sec18p, which further 
lends credence to our hypothesis that Sec18p is released from a PA bound pool and then 
recruited to cis-SNARE complexes. 
 
Lastly, since Pah1p dephosphorylates PA to DAG and the deletion of Pah1p results in 
elevated levels of PA on the membrane, we asked if altering the ratio of these two lipids on the 
membrane by deleting Pah1p in vacuoles would affect Sec18p association. Dgk1 encodes a DAG 
kinase, which is the enzyme responsible for phosphorylation of DAG  to PA. We reasoned that if 
the deletion of Pah1p results in PA accumulation, the Dgk1 deletion would result in the 
accumulation of DAG on the vacuole membrane and would provide us a good tool to study the 
effect of vacuole lipid composition on Sec18p association. Vacuoles from the above mentioned 
strains were used in a standard fusion reaction and incubated in the presence of 100 nM GST-
Vam7p. cis-SNARE complexes were isolated by immunoprecipitating the GST tagged Vam7p 
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and associated Sec18p was analyzed. Pah1p deletion results in reduced Sec18p recruitment to the 
cis-SNARE complexes, presumably due to an increased amount of Sec18p in the PA bound pool 
and thus leaving less of it available to be recruited to the cis-SNARE complexes (Fig 3.5). The 
levels of associated Sec18p returned to WT levels in strains where the Pah1 deletion was 
complemented with a PAH carrying plasmid indicating that the Pah1p is critical for Sec18p 
recruitment during priming. Interestingly, we observed increased Sec18p recruitment in Dgk1 
deleted vacuoles. We reason that when the DAG kinase is deleted, PA bound Sec18p would be 
released by the PAP activity of Pah1p but the reverse reaction producing PA from DAG is 
abolished thus resulting in diminished reserves of PA on the vacuole membrane. These 
diminished reserves might not be sufficient to sequester enough Sec18p and hence more of the 
Sec18p is available to be recruited to the cis-SNARE complexes during priming. Based on the 
data above, we conclude that Pah1p is the factor responsible for the recruitment of Sec18p to cis-
SNARE complexes during priming and the change in the membrane lipid composition is the 
trigger responsible for the distribution of Sec18p between the PA bound and cis-SNARE bound 
pools 
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DISCUSSION 
 
In this study, we delved deeper into the role of the yeast PA phosphatase Pah1p during 
membrane fusion. In an earlier study, we reported PAHI as a factor essential for priming and 
Sec17p release during priming (19). It was also reported that the deletion of PAHI resulted in a 
drastic reduction in the amount of Sec18p associated with the SNARE complex during priming. 
Here, we shed light and provide a deeper understanding of the role of Pah1p during priming in 
membrane fusion. We demonstrate that the PAP activity of Pah1p is responsible for the 
recruitment of Sec18p to cis-SNARE complexes during priming. The absence of Pah1p or 
inhibition of its PAP activity results in a failure of Sec18p recruitment to the site of fusion which 
translates to a defect in priming and hence membrane fusion. 
 
We have demonstrated a specific interaction between the Sec18p and PA using both 
protein-lipid overlay and liposome association assays. With the use of lipid specific protein 
domains we have successfully demonstrated that Sec18p interaction with phosphatidic is a direct 
physical interaction and possibly serves to sequester Sec18p on the membrane. Another 
overlooked aspect of the Sec18p-PA interaction could be in part due to the local curvature 
changes induced by the presence of PA on the membrane (36). It is possible that islands of PA 
rich regions on the membrane display significantly different local curvature than the bulk of the 
membrane and Sec18p serves to sense this difference in curvature in order to bind the membrane. 
 
 In protein lipid overlay and liposome association assays, Sec18p bound equally well to 
both PA and DAG. The only difference in Sec18p interaction with either lipid was observed 
when the mole percent of either of these lipids was increased on the membranes. The increase in 
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mole percent of PA resulted in increased Sec18p association with the membrane. On the other 
hand, increasing the percentage of DAG resulted in reduced Sec18p association. In the context of 
membrane fusion, these experiments mirror the events immediately preceding priming and 
SNARE disassembly. The activity of Pah1, preceding priming, would result in more and more 
PA being converted to DAG and over the course of time result in a decrease in the local 
concentration of PA and an increase in the local concentration of DAG. Based on our data from 
the liposome association assays, it is possible that as the conversion of PA to DAG proceeds, 
progressively less Sec18p is bound to these PA rich regions and hence more Sec18p is available 
to be recruited to cis-SNARE complexes. 
 
It has been reported that NEM inhibits the ATPase activity of NSF, which is the 
mammalian homologue of Sec18p, but was ineffective against Sec18p itself (23). We 
demonstrate that NEM does infact inhibit membrane fusion and more specifically the priming 
stage of fusion. By isolating cis-SNARE complexes, we found that NEM inhibits the recruitment 
of Sec18p to cis-SNARE complexes during priming. The effect of NEM on Sec18p recruitment 
seems to be unrelated to its ATPase activity. It is possible that NEM changes the conformation of 
Sec18p such that it affects cis-SNARE binding without affecting its ATPase activity.  
 
Propranolol, a small molecule inhibitor of the PAP activity of Pah1p has been shown to inhibit 
membrane fusion by inhibiting priming (19). Here, we demonstrate a defect in Sec18p 
recruitment to -SNARE complex during priming in the presence of propranolol. Taken together, 
we conclude that the PAP activity of Pah1p is essential for the recruitment of Sec18p during 
priming. The phosphatase activity of Pah1p results in the production of DAG from PA. Deletion 
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of Pah1p resulted in a defect in Sec18p recruitment. On the contrary, deletion of Dgk1, the DAG 
kinase, results in an increased Sec18p recruitment. Both Pah1p and Dgk1, function by altering 
the lipid composition of the membrane during membrane fusion. Deletion of Pah1 results in the 
accumulation of PA whereas a deletion of Dgk1 results in the accumulation of DAG on the 
membrane. Taken together, it is possible that Pah1p serves to kick start priming by altering the 
lipid composition of the membrane, which then results in Sec18p being recruited to the cis-
SNARE complexes at the site of priming. This study underlines the role of membrane lipid 
composition in the recruitment of fusion factors to the site of fusion. 
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MATERIALS AND METHODS 
 
Reagents 
All reagents were diluted in PS buffer (20 mM PIPES-KOH pH 6.8, 200 mM sorbitol) to a 
working concentration before use in experiments. Antibodies against, Sec17p  and Sec18pp have 
been described previously. NEM, propranolol hydrochloride and ATPyS were bought from 
Sigma Aldrich and dissolved in PS buffer All the lipids used in this study: POPA (palmitoyl 
oleoyl PA), POPC (palmitoyl oleoyl phosphatidylcholine), POPE (palimitoyl oleoyl 
phosphatidylethanolamine), and POG (palmitoyl oleoyl glycerol) were bought from Echelon 
biosciences as stock solutions dissolved in chloroform and stored at -20ºC.  
 
Recombinant proteins 
Recombinant His tagged Sec18p was purified from the cytosolic fraction of BL-21 derived 
Rosetta competent cells (EMD Biosciences) as described before (23). Briefly, CBB214 strain of 
XL-1 blue competent cell carrying the PQE9-His Sec18p plasmid were streaked LB agar plates 
containing 100 µg/ml ampicillin and 12 µg/ml tetracycline. A single colony was used to start an 
overnight 100 ml preculture in LB. The next day, culture flasks containing 1L terrific broth were 
inoculated with 50 ml of the preculture and the cells were grown at 37ºC. Once the optical 
density reached 0.9, cells were induced with 200 µM IPTG at 37ºC overnight for 4 hours. The 
next day, cells were harvested in 50ml lysis buffer (10 mM HEPES-KOH  pH 7.0), 500 mM 
KCl, 5 mM ATP, 5 mM MgCl2, 2 mM β-mercaptoethanol, 1 mM PMSF and protease inhibitor 
cocktail).  The cell suspension was subjected to lysis in a french pressure cell and the lysate 
cleared by centrifugation at 16,000 rpm, 4ºC for 30 minutes in a JA-20 rotor. For further 
clarification, the lysate was subjected to centrifugation at 250,000g for 1 hour at 4º C in a 
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60Ti rotor. The cleared lysate was loaded onto a Ni-NTA agarose column and the protein was 
allowed to bind for 2 hours at 4ºC. The column was washed using buffer A (20 mM HEPES-
KOH pH 7.0, 200 mM KCl, 1 mM MgCl2, 0.5 mM ATP, 2 mM β-mercaptoethanol, 10% 
glycerol and 50 mM Imidazole). His-Sec18p was eluted from the column using buffer A 
containing 500 mM Imidazole. The eluted protein was further purified on a Gel flitration column 
pre-equilibriated with GF buffer ( 20 mM PIPES-KOH pH 6.8, 200 mM Sorbitol, 125 mM KCl, 
5 mM MgCl2, 2 mM ATP, 2 mM DTT and 10% glycerol) and 1ml fractions were collected. 
Sec18p elutes from the column as two distinct populations: the hexameric pool with a molecular 
mass of 640 kDa elutes early (fraction peak around 50 ml post injection) and the later dimeric 
pool with estimated molecular mass of 140 kDa. The hexameric pool of Sec18p was used in all 
out experiements. Recombinant His-TGD2 was purified according to the protocol described 
earlier (24,25) dialysed into PS buffer containing 125 mM KCl, aliquoted and stored at -80ºC. 
 
Strains 
BJ3505 (MAT pep4::HIS3 prb1-1.6R his3-200 lys2-801 trp1101(gal3) ura3-52 gal2 can1) 
and DKY6281 (MAT  leu2-3 leu2-112 ura3-52 his3-200 trp1-901 lys 2-801) were used for 
standard vacuole fusion assays (26). BJ3505 and DK6281 CBP-Vam3p strains harboring a 
Nyv1deletion were used for the isolation of cis-SNARE complexes (27). Pah1p deleted strains 
RFY 17 and RFY 18 and WT PAH1 plasmid complemented strain RFY 19, 20 have previously 
been described (19).Yeast strains where DAG kinase, Dgk1 has been deleted (SS1144) and 
where both Dgk1 and Pah1p have been deleted (SS1147) have been described earlier (28). 
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Vacuole Isolation and in vitro vacuole fusion 
Vacuoles were isolated from yeast strains by floatation (29). Fusion reactions (30 l) contained 3 
g each of vacuoles from BJ3505 (pep4∆ PHO8) and DK6281 (PEP4 pho8∆), fusion assay 
buffer (125 mM KCl, 5 mM MgCl2, 20 mM PIPES-KOH pH 6.8, 200 mM sorbitol), ATP 
regenerating system (1 mM ATP, 29 mM creatine phosphate, 0.1 mg/ml creatine kinase), 10 M 
CoA and 283 nM IB2. Reactions were incubated at 27C for 90 min and the Pho8p activity was 
measured in 250 mM Tris-Cl PH 8.5, 0.4% Triton X-100, 10 mM MgCl2, 1 mM p-
nitrophenylphosphate. During fusion, Pep4p protease gains access to the pro-alkaline 
phosphatase (proPho8p) and cleaves it to form mature alkaline phosphatase. The extent of fusion 
and hence alkaline phosphatase maturation was measured by measuring the quantity of p-
nitrophenylate produced was measured at 400 nm. One unit of fusion was defined as 1 mol of 
p-nitrophenylate produced min
-1
 g-1 of pep4 vacuoles. 
 
Protein Lipid Overlay Assay 
Stock lipids of POPA (palimitoyl oleoyl phophatidic acid) and POG (palmitoyl oleoyl glycerol) 
were diluted to the indicated concentration in a methanol, chloroform and water mixture 
(2:1:0.8). 5 µl of each lipid from each dilution was spotted on a Hybond—C extra membrane and 
allowed to dry at room temperature for 1 hour. The membrane was blocked with 5% BSA 
solution in TBST for 1 hour at room temperature. Recombinant His-Sec18p was diluted to 2.5 
nM concentration in blocking buffer and the membrane incubated with the protein at 4ºC 
overnight. The membrane was washed 3 times over 30 minutes followed by incubation with the 
primary antibody directed against Sec18p for 1 hour. Again, the membrane was washed 3 times 
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over 30 minutes and incubated with secondary antibody (goat anti-rabbit IgG) for 1 hour. After a 
final wash, Sec18p bound to the membrane was detected by development of a fluorescence 
signal following incubation of the membrane with the ECF substrate (GE healthcare).  
 
Liposome Preparation and Co-Floatation Assay 
SUV liposomes containing different lipid compositions were prepared using the sonication 
method. Briefly, stock lipids in chloroform were mixed to produce a lipid mixture with the 
desired lipid mole percentages containing 2.6 µmoles of total phospholipids. The lipid mixture 
was dried under a gentle stream of nitrogen and dried in a speed-vaccum for an additional 60 
minutes until a milky white layer of lipids appears on the glass walls. The tubes were left under a 
steady vaccum stream in a dessicator overnight. To the dried lipids, 2.6 ml of 1X PBS solution 
was added, the tubes were covered with parafilm and allowed to sit at room temperature for an 
hour.  The tubes were vortexed well to resuspend the lipids completely and sonicated in a water 
bath sonicator for 30 minutes, till a slightly hazy suspension appears. The result was a uniform 
suspension of liposomes containing 1 mM phospholipids in PBS. To measure protein binding to 
the liposomes, 2 µg of recombinant His -Sec18p was incubated with 1 ml of the 1 mM liposome 
suspension for 2 hours at room temperature. Following which, the bound and unbound Sec18p 
were separated on a 5-20% sucrose gradient by ultracentrifugation at 55000 rpm for 3 hours in a 
Ti60 rotor. The liposomes floated up to the interface between 0% and 10% sucrose. Liposome-
bound Sec18p was then analysed by western blotting. To study the effect of different inhibtors 
on Sec18p binding, the protein was incubated with each of the different inhibitors 2 mM 
propranolol, 3 mM NEM, 2 mM MgCl2 or 1X ATP regenerating system containing ATPγS for 1 
hour at 4ºC before allowing it to bind liposomes. For competition assays, 10 times molar excess 
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of His-TGD2 or GST-C1b was allowed to bind the liposomes at room temperature for 2 hours 
before Sec18p binding and gradient centrifugation. 
 
CBP Pull-down assay 
Sec18p-SNARE complexes were isolated and analyzed as described with some minor 
modifications (30). Large-scale 16X (480 l) fusion reactions containing 48 g of vacuoles from 
BJ3505 CBP-Vam3p and 48 g of vacuoles from DK6281 CBP-Vam3p backgrounds were 
incubated in the presence of buffer or different fusion modulators (2 mM propranolol, 3 mM 
NEM, 2 mM MgCl2 and 1X ATP regenerating system containing ATPγS). After incubation at 
27C for 10 min, reactions were placed on ice for 5 min and 30 l was withdrawn from each 
sample to assay Pho8p activity. The remaining samples were centrifuged (16000 g, 15 min, 4C) 
to sediment the vacuoles and the supernatants were discarded. Vacuole pellets were overlaid with 
200 l ice-cold solubilization buffer (20 mM Tris-Cl pH 7.5, 150 mM NaCl, 1 mM MgCl2, 0.5% 
Triton X-100 and 20% glycerol) with protease inhibitors (0.46 g/ml leupeptin, 3.5 g/ml 
pepstatin, 2.4 g/ml Pefabloc-SC and 1 mM PMSF) and gently resuspended. Solubilization 
buffer was added to a final volume of 400 l and the extracts were mixed by nutating at 4C. 
After 20 min, insoluble debris was removed by centrifugation (16,000 g, 20 min, 4C). 
Supernatants were transferred to fresh tubes and 10% of the extract was saved for input samples. 
The remaining extracts were brought up to 2 mM CaCl2 and incubated with 40 l calmodulin 
Sepharose beads equilibrated with solubilization buffer (GE Healthcare; 4C, 12 h, nutating). 
The beads were collected by centrifugation (3,000 g, 2 min, 4C) and washed five times with 1 
ml of solubilization buffer containing 1% Triton and 2 mM CaCl2 followed by bead 
centrifugation. Bound proteins were eluted with solubilization buffer containing 0.1% Triton X-
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100 and 5 mM EGTA. The eluents were mixed with SDS sample buffer and used for SDS-PAGE 
analysis and immunoblotting. 
 
GST Pull-down assay 
Sec18p associated with cis-SNARE complexes was analysed by modifying the GST-Vam7p 
pulldown assays described earlier. Briefly, 10X fusion reactions containing WT, pah1Δ, dgk1Δ 
or the double mutant pah1Δ dgk1Δ vacuoles were incubated with 100 nM GST-Vam7p at 27ºC 
for 10 min. At the end of 10 min, vacuoles were sedimented by centrifugation at 13000 rpm for 
10 minutes. The pellets were solubilized with 200 µl solubilization buffer ( 20 mM HEPES-KOH 
pH 7.4, 100 mM NaCl, 2 mM EDTA, 20% glycerol, 0.5% Triton X-100, 1 mM DTT, 1 mM 
PMSF, 1X PIC)  and the insoluble debris pelleted by centrifugation at 13,000 g for 10 min. To 
the supernatant, 80 µl of 25% GSH bead slurry (equilibriated in solubilisation buffer) was added 
and incubated overnight at 4ºC. The beads were pelleted and washed 5 times with 1 ml of 
solubilisation buffer. After the final wash, bound proteins were eluted with 40 µl of SDS sample 
loading buffer. GST-Vam7p associated Sec18p was analyzed by western blotting. 
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FIGURES 
 
This research was originally published in JBC. Sasser et al. JBC. 2012.,287:2221-2236 
.© The American society for Biochemistry and Molecular Biology 
 
Fig 3.1. Pah1p activity is required for effective priming. (A) Standard fusion reaction were 
incubated with increasing amounts of propranolol at 27ºC for 90 minutes and membrane fusion 
measured in an alkaline phosphatase fusion assay. (B) 10X standard fusion reaction containing 
WT or Pah1 deleted vacuoles were incubated at 27ºC for 90 minutes. At the end of 90 minutes, 
vacuoles were reisolated by centrifugation, resuspended in SDS sample buffer, resolved by SDS-
PAGE and and immunoblotted for Sec17 and Actin.  
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Fig 3.2. Sec18p interacts with both PA and DAG on liposomes. 
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(A) Protein lipid overlay assay: Increasing dilutions of the two lipids POPA and POG were 
spotted on a nitrocellulose membrane and protein binding (TGD2 or Sec18p) to the lipids was 
examined by immunoblotting as detailed in the Materials and Methods section. (B-D) Liposomes 
containing the indicated lipid composition were prepared as described, incubated with 2µg of 
purified recombinant His-Sec18p and the liposome bound Sec18p was reisolated using a 5-20% 
Sucrose gradient. Immunoblots showing Sec18p bound to PA and DAG containing liposomes 
(B), bound to liposomes containing increasing mole percentages of PA or DAG (C) and bound to 
liposomes  pre-treated with 10 times molar excess of TGD2 (to block PA) or GST-C1b (to block 
DAG) (D) are shown. Immunoblots are representative of 3 independent trials. 
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Fig 3.3. NEM and TGD2 inhibit membrane fusion.  
 
(A) Standard fusion reactions were treated with increasing concentrations of NEM for 90 
minutes at 27C. Fusion was tested by content mixing and measuring Pho8p activity. (B) 2 mM 
propranolol, 3 mM NEM or anti-Vam3p IgG were added to standard fusion reactions at indicated 
times, after the start of fusion. The extent of resistance gained to these inhibitors was measured 
by measuring fusion at each of these time points. (C). Standard fusion reactions were treated 
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with 2 mM Propranolol, 3 mM NEM, 2 mM MgCl2 or 1X ATP regenerating system containing 
ATPγS at 27ºC for 90 minute and membrane fusion measured with the alkaline phosphatase 
maturation assay. (D) 2 µg of Sec18p was treated with buffer, 2 mM propranolol, 3 mM NEM, 2 
mM MgCl2 or ATPγS for 30 minutes at room temperature before subjecting it to the liposome 
association assay. Error bars represent SEM (n=3). 
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Fig 3.4. The nucleotide bound state of Sec18p dictates its recruitment to the cis-SNARE 
complexes during priming. 
(A) Standard 10X fusion reactions were treated with 2 mM Propranolol, 3 mM NEM, 2 mM 
MgCl2 or 1X ATP regenerating system containing ATPγS. The reactions were either left on ice 
or incubated at 27C for 10 min. Following which, vacuole membranes were sedimented by 
centrifugation and subjected to immunoblot analysis to isolate the membrane bound fraction of 
Sec18p following various treatment conditions. (B) 16X standard fusion reactions containing 48 
g of BJ3505 CBP-Vam3p nyv1 vacuoles and 48 g DK6281 vacuoles were treated with 2mM 
Propranolol, 3 mM NEM, 2 mM MgCl2 or 1X ATP regenerating system containing ATPγS. The 
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reactions were immediately placed on ice or allowed to incubate at 27ºC for 10 minutes and 
centrifuged to isolate the total membrane fraction. Membranes were then solubilized and CBP-
Vam3p complexes were affinity purified using calmodulin agarose as described in the Materials 
and Methods. Trans-SNARE complexes were detected by immunoblotting for Vam3p, Nyv1p 
and Vam7p. The Image shown is representative of 3 independent trials 
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Fig 3.5. . Pah1p is essential for the recruitment of Sec18p to cis-SNARE complexes during 
priming.  
Standard 10X fusion reactions containing vacuoles isolated from wildtype, pah1p deleted, pah1p 
complemented or Dgk1 deleted yeast strains were incubated for 10 min at 27ºC in the presence 
of 100 nM GST-Vam7p. Vacuoles were sedimented by centrifugation, the membrane solubilized 
and incubated with Glutathione sepharose beads overnight at 4ºC. GST-Vam7p containing 
complexes were eluted from the Glutathione beads and the bound Sec18p was analysed by 
immunoblotting. 
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Overview 
 
 
In this study, we have attempted to redefine the role of the membrane in vacuole 
membrane fusion. We have focused on two distinct properties of the membrane arising from it’s 
constituent lipids: the physical properties such as curvature, lateral membrane tension and 
fluidity which are an indirect result of the different lipid shapes and their lareral distribution on 
the membrane and the chemical property such as lipid composition, which is a direct result of the 
equilibrium and conversion between different lipids on the membrane. In chapter II, we 
manipulate the curvature and lateral tension of the membrane using curvature altering agents 
such as Chlorpromazine and Lysophosphatidylcholine and study the effect of the these 
parameters on the function of the SNARE complex in effecting fusion. In chapter III, we zoom in 
and focus on a single metabolic reaction responsible for maintaining the levels of phoshatidic 
acid and DAG on the membrane and study the role this lipid metabolic pathway in recruitment of 
a key ATPase protein during priming. 
 
Role of Membrane Curvature in Vacuole Membrane Fusion 
 
CPZ is an amphipathic small molecule that traverses the lipid bilayer and inserts itself 
into the inner leaflet of membranes thereby increasing the negative curvature of the outer leaflet 
of the bilayer (1). A wealth of knowledge on the effects of CPZ on membrane physical properties 
has been gained from force measurements on the outer hair cell of the mammalian cochlea. CPZ 
decreases the steady state tethering force and increases lateral lipid mobility in outer hair cell 
membrane tethers (2). It also decreases the lateral cell wall tension required for vesicle 
generation in the plasma membrane of the outer hair cell (3). Lysophosphatidylcholine (LPC), on 
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the other hand, is an inverted cone shaped lipid and intercalates into the outer leaflet of 
membranes leading to an increase in both positive curvature and tension (4). LPC has been 
reported to inhibit fusion by inhibiting stalk formation (5).  Using these two small molecules to 
manipulate membrane curvature and lateral tension, we report that decreasing the membrane 
lateral tension with negative-curvature inducing agents such as CPZ, decreases the effectiveness 
of the SNARE complex during fusion (Fig 2.1.C). In the presence of non-canonical SNARE 
complexes, which exert insufficient pulling force to effect force, decreasing the membrane 
tension with CPZ, allows more of the non-productive SNARE complexes to reach the force 
threshold for fusion by lowering the threshold (Fig 2.1.A). On the other hand, increasing the 
membrane curvature and lateral tension with LPC, resulted in increasing the force threshold such 
that even the canonical, productive SNARE complexes couldnot effect membrane fusion (Fig 
2.2). Interestingly, the opposing effects of positive and negative- curvature inducing molecules 
did not simply cancel each other in the context of membrane fusion. Instead, we report that the 
membrane experiences local regions of either positive or negative curvature during different 
stages of fusion. The positive curvature inducing agent, LPC, inhibits the formation of a fusion 
stalk whereas, negative-curvature inducing CPZ promotes the transition from hemifusion to 
complete fusion.  
 
Role of Pulling-Force Generation by the trans-SNARE Complex  
 
The central ionic residue of SNARE motifs is conserved throughout eukaryotes and is 
essential for fusion, and each fusogenic SNARE bundle is composed of 3 Q-SNAREs and 1 R-
SNARE (3Q:1R). Previously, we found that point mutations yielding 2Q:2R complexes were 
fusion incompetent and that fusion was restored when lateral membrane tension was reduced 
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with chlorpromazine (CPZ) (6). Our previous studies showed that WT and Vam7p
Q283R
 form 
trans-SNARE complexes successfully (6), yet fusion required a 10-fold excess of Vam7p
Q283R
 to 
reach WT levels of fusion. Thus, we hypothesized that Vam7p
Q283R
 forms weaker SNARE 
bundles that do not exert sufficient force to reach the activation energy of fusion.  We further 
report that the 2Q:2R complexes can still be made fusion competent by increasing their surface 
density (Fig 2.3.A). These data demonstrate that non-canonical SNARE complexes can 
overcome the activation energy barrier required for hemifusion-fusion transition when the 
surface density of the mutant SNARE complexes is multiplied. Interestingly, the overexpression 
of SNARE proteins on the vacuole surface, bypasses the requirement for the HOPS complex and 
the proofreading mechanism, thus allowing the non-canonical complexes to effect fusion. 
 
Role of the SNARE Transmembrane Domain in Hemifusion-Fusion Transition 
During Membrane Fusion 
 
It is widely accepted that the formation of the helical SNARE bundle pulls and distorts 
the apposed membranes together to activate fusion. Here the energy generated from the 
formation of the SNARE complexes is transmitted to the membrane through the TMDs at the 
point of contact between the bilayers. Previous work by others has shown that the TMD of the 
vacuolar SNARE Vam3p is essential for productive priming and supporting fusion (7). Also, 
cells carrying a GPI anchored HA were stalled in the hemifusion stage and could not achieve 
complete fusion with RBCs. The defect in fusion has been attributed to the absence of a TMD 
and the fact that the GPI anchor only traverses the outer leaflet of the bilayer (8,9). Although the 
sequence is not as critical, there is a stringent requirement on the length of the TMD to achieve 
full functionality. Truncation mutants in the TMD of HA revealed a strict requirement of atleast 
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17 amino acids to successfully effect fusion. TMDs smaller than the critical length, could not 
span the entire length of the bilayer and were stalled at the hemifusion stage (10). On the other 
hand, increase in the separation between the coiled-coil and the transmembrane domain (by 
insertion of a flexible linker) also drastically reduced fusion, possibly by relieving the strain 
generated on the membrane (11). 
We report that the TMD in the Q-SNARE Vam3p serves to transmit the pulling force 
generated by the trans-SNARE complex to the membrane. The TMD was replaced with a 
flexible lipid anchor, which resulted in successful inner leaflet mixing but defective outer leaflet 
mixing and hence the fusion reactions were stalled in the hemifusion stage (Fig 2.4.B). These 
hemifusion stalled fusion reactions could then be pushed to make the hemifusion to fusion 
tranisition by lowering the lateral membrane tension with Chlorpromazine. We also report that 
the absence of a TMD combined with a defective 2Q:2R SNARE complex, produces insufficient 
pulling-force which is not transmitted to the membrane and hence lowering the lateral membrane 
tension with CPZ had not effect on this particular combination (Fig 2.5.A). As expected, the 
absence of the Q-SNARE TMD in both the partner vacuoles resulted in a severe break in force 
transmission that any combination of the SNARE complex (3Q:1R or 2Q:2R) with CPZ couldnot 
effect fusion (fig 2.5.B). 
 
Role of Pah1p in Sec18p Recruitment During Priming  
 
Among the three major PA phosphatases present in yeast, neither LPP1 nor DPP1 are 
implicated in vacuole fusion. However, deletion of Pah1p resulted in severe vacuole 
fragmentation which upon further investigation revealed two major defects in the vacuole fusion 
machinery: a defect in priming and protein sorting to the vacuole. Pah1 deleted vacuoles were 
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characterized by a failure in Sec17 release and drastically reduced levels of the  Sec18p, a AAA 
ATPase responsible for cis-SNARE disassembly, at the site of priming (12). In chapter III, we 
delve deeper into the mechanism of Pah1p action during priming.  
Propranolol, a small molecule inhibitor of the PAP activity of Pah1p has been shown to 
inhibit membrane fusion by inhibiting priming (12). Here, we demonstrate a defect in Sec18p 
recruitment to cis-SNARE complex during priming in the presence of propranolol (Fig 3.4.B). 
We report that the PAP activity of Pah1p is essential for the recruitment of Sec18p during 
priming. Inhibition of Pah1p activity also resulted in a defective Sec18p recruitment to the cis-
SNARE complexes (Fig 3.4 and Fig 3.5.).  We envision a scenario wherein, Sec18p is held on 
the membrane at PA rich domains prior to the start of fusion. During priming, following the 
conversion of PA to DAG by Pah1p, Sec18p falls off the PA rich domain and is recruited to the 
cis-SNARE complexes 
 
Role of the Membrane Lipid-Composition in Membrane Fusion 
 
Deletion of Pah1p, the PA phosphatase resulted in defective Sec18p recruitment to the 
cis-SNARE complexes during Priming. On the contrary, deletion of Dgk1, the DAG kinase, 
results in an increased Sec18p recruitment (Fig 3.5). Both Pah1p and Dgk1function by altering 
the membrane lipid-compositionduring fusion. Deletion of Pah1 results in the accumulation of 
PA whereas a deletion of Dgk1 results in the accumulation of DAG on the membrane. We 
hypothesise that Pah1p serves to kick start priming by altering the lipid composition of the 
membrane, which then results in Sec18p being recruited to the cis-SNARE complexes at the site 
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priming. This study underlines the role of membrane lipid composition in the recruitment of 
fusion factors to the site of fusion. 
Lipid composition can change the local physical properties of the bilayer, yet the 
mechanisms by which these lipids regulate fusion remain uncertain. Regulatory lipids such as 
sterols and sphingolipids serve to thicken and stiffen raft microdomains, whereas others are 
essential for the recruitment and activation of soluble proteins (13,14). A third function of 
regulatory lipids in these microdomains is the focused destabilization of the bilayer. Lipids such 
as DAG are known to induce negative curvature and destabilize bilayers (15,16). The negative 
curvature induced by DAG and its enrichment at the vertex ring is consistent with the occurrence 
of a hemifusion intermediate (17). This is also in keeping with the stalk hypothesis of hemifusion 
where the fusion stalk contains negative curvature structures (18). Formation of the stalk is 
energetically disfavored by the insertion of LPC and creation of positive curvature in the outer 
layer of the membrane. Our finding that CPZ can overcome the inhibited fusion caused by C1b 
emphasizes this importance of DAG in creating negative curvature and destabilizing the 
membrane. We posit that binding DAG with C1b inhibits the lipid from inducing negative 
curvature and that CPZ restores the negative curvature needed for fusion 
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